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Abstract 
Slow and Steady: 4-Phenylthiobutanoic Acid Inhibits Histone Deacetylase 8 to Enhance 
Post-Acute Kidney Injury Repair 
 
Hwa In Han, PhD 
 
University of Pittsburgh, 2020 
 
 
Acute kidney injury (AKI) is a rapid decline in kidney function that is associated with high 
mortality and morbidity rates, affecting 1 in 5 adults worldwide 1. While damaged renal tubular 
epithelial cells (RTECs) undergo reparative process to proliferate and replace the damaged 
epithelium, it is not a robust mechanism. The initial damage is followed by a cross-talk of innate 
immune system and RTECs resulting in exacerbation of inflammation, fibrosis, and sometimes 
irreversible damage. Despite the prevalence and severity of AKI, no FDA approved therapeutics 
exist to replace damaged or lost RTECS. Therefore, it is imperative to screen, identify, and 
understand mechanisms with which candidate therapeutics can enhance repair. Our group 
identified 4-phenylthiobutanoic acid (PTBA) and developed analogs to enhance renal repair when 
treated post-AKI. However, the protein target(s) as well as the mechanisms responsible for 
enhanced recovery are not completely understood. Here, we used a zebrafish larvae AKI model to 
visualize RTEC cellular response during PTBA treatment. We also characterized the zebrafish 
immune response during AKI and the effect of PTBA on modulating the innate immune cell 
response. Lastly, we used in vivo and in vitro methods to identify the target of PTBA, Histone 
deacetylase 8 (HDAC8). Using knockout hdac8 (hdac8-/-) zebrafish, we showed a similarly 
enhanced recovery of hdac8-/- as we saw in animals treated with PTBA. We further demonstrated 
the hdac8-/- show changes cell cycle dynamics and epithelial to mesenchymal transition. Taken 
together, our work provides another step forward in pro-regenerative compound development.   
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1.0 Background 
1.1 Kidney development, structure, and function 
1.1.1 Mammalian kidney development 
During development, the vertebrate kidney transitions through the three distinct kidney 
structures that are marked by increasing numbers and organization of nephrons. They are termed 
pronephros, mesonephros, and metanephros, in the order of the least number of nephrons to the 
greatest number of nephrons. In the mammalian, avian, and reptilian kidney, the pronephros and 
mesonephros arise during the embryonic development then become vestigial structures 2. Further 
along in embryonic development, the metanephric kidney is formed, becoming the final kidney 
structure used throughout the life of the animal 2,3. In the teleost and amphibian kidney, the 
pronephros serves as a functional embryonic kidney until a second wave of nephrogenesis occurs 
to form the mesonephros, the final kidney structure used by the adult animal 4.  
The mammalian kidney arises from the intermediate mesoderm (IM) during development, 
specializing into different cell types via spatially and temporally regulated molecular signals 3,5. 
The renal progenitor cells (RPC) that co-express LIM homeobox1 (Lhx1)/ Paired box gene 2 
(Pax2)/ Paired box gene 8 (Pax8) are first observed in a set of bilateral epithelial tubes called the 
Wolffian duct 6 (Figure 1A). The rostral ducts function as the pronephric tubule but disintegrates 
overtime 2. The elongated, caudal duct give rise to branching nephrons and serves as the 
mesonephros 2 (Figure 1B). The metanephric kidney forms at the caudal end of the Wolffian duct 
6 (Figure 1B). The Wolffian duct is juxtaposed to metanephric mesenchyme (MM) and the two 
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tissues exchange various signals to initiate metanephros formation. RET tyrosine kinase (Ret) and 
Glial cell line-derived neurotrophic factor (GDNF) signaling is required for the Wolffian duct to 
invade the MM then branch, determining the final number of nephrons in the metanephric kidney 
7 8 9(Figure 1B,C). Subpopulations of cells in the cap mesenchyme (CM) express various 
multipotent progenitor markers that differentiate into different kidney cell types (Figure 1D). 
Subpopulation of Forkhead transcription factor D (Foxd)+ cells differentiate to interstitial cells and 
Fetal liver kinase-1 (Flk1)+ cells contribute to the renal vasculature 10 11. Cells co-expressing SIX 
Homeobox 2 (Six2) and CREB-binding protein/p300-interacting transactivator with ED-rich tail 
2 (Cited2) undergo mesenchymal to epithelial transition (MET) to become renal vesicles 12 13 
(Figure 1D). The renal vesicles continue to specify, receiving complex signaling cascade to initiate 
segmentation specification (Figure 1D). For example, the glomerulus is specified by Wilm’s 
tumor1 (Wt1) and the proximal segment is specified by Pax2 4 (Figure 1). During specification, 
the renal vesicle undergoes structural changes into a comma-shaped body, a s-shaped body, then 
ultimately to a fully differentiated and segmented nephron (Figure 1D). Each fully differentiated 
nephron is composed of segments expressing various transporters to reuptake solutes and water to 
reabsorb essential molecules and maintain osmotic balance. 
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Figure 1 Mammalian kidney development 
Stages of mouse kidney development. (A) Intermediate Mesoderm (IM, purple) specification at E8 (A’) The renal 
progenitor cells within IM (purple) express Pax2a, Pax8, and Lhx1a (B) Pro-, meso-, metanephros formation. Wolffian 
duct (Green) is the original epithelial tube that becomes elongated from rostral to caudal. (C) Menatenprhos 
organogenesis at E11-E13.5. Ureteric bud branches Cap mesenchyme (CM), ureteric bud (UB), metanephric 
mesenchyme (MM). (D) Nephrogenesis. Pretubular aggregate continue to specify to renal vesicle (D’), comma shaped 
body (D’’), and s-shaped body (D’’).  
1.1.2 Zebrafish kidney development 
The zebrafish kidney undergoes similar developmental signaling pathways as the 
mammalian kidney. The RPCs co-express lhx1a/pax2a/pax8 within the IM in the tailbud stage 14 
15 (Figure 2A). Like the mammalian system, the RPCs undergo MET transition to form two 
  4 
bilateral tubules that eventually form the two pronephric kidneys. Within the IM the RPC field 
responds to a retinoic acid (RA) gradient secreted from the outer paraxial mesoderm (Figure 2B), 
with the high caudal RA specifying the glomerular and proximal segments 16 3. Like the 
mammalian glomerulus, the zebrafish glomerulus requires wt1 expression while pax2a and pax8 
are required for proximal tubule segmentation (Figure 2B). By 24 hours post fertilization (hpf), 
the segmentations become distinct and the pronephros becomes functional at 72-96hpf 17 (Figure 
2). At 10dpf, zebrafish undergo postembryonic metamorphosis from larva to juvenile 18. 
Concurrently, the second wave of nephrogenesis occurs, resulting in the mesonephros comprised 
of hundreds of nephrons 18. The mesonephric anlagen form on top of and then fuse with the 
pronephric tubules, with increased expression of RPC which epithelialize into renal vesicle-like 
bodies to elongate into nascent nephrons and fuse with the pronephric tubule 18. The mesonephros 
serves as the terminal functioning kidney for adult zebrafish. 
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Figure 2 Zebrafish kidney development 
Stages of zebrafish kidney development. (A) Intermediate Mesoderm (IM, purple) specification at 12hpf (A’) The 
renal progenitor cells within IM (purple) express pax2a, pax8, and lhx1a. (B) Pronephros epithelialization 16-24hpf. 
(B’) Proximal versus distal segmentation is determined by (among other factors) RA gradient and wt1a, pax2a, and 
pax8 expression. (C) Differentiation of pronephric tubule and glomerulus 30-40hpf (D) Top view of zebrafish 
pronephros. They are composed of  two bilateral nephrons with one fused glomerus. 
1.1.3 Nephron segmentation 
In the human metanephric kidney, the branching process results in a complex kidney 
approximately 200,000 to 2 million nephrons, each nephron serving as a working unit of filtration 
19 (Figure 3A). In comparison, the zebrafish kidney pronephric kidney is simpler, resulting in two 
nephrons (Figure 3B). However, the function of the metanephric and pronephric nephrons both 
function to filter blood, excrete metabolites, uptake essential nutrients, and produce urine as its 
  6 
final product 20. The mammalian nephron is comprised of single sheet of renal tubular epithelial 
cells (RTECs) and is segmented into the glomerulus, proximal tubule (PT), Loop of Henle, distal 
tubule (DT), and collecting duct (CD) (Figure 3A,C). Main segments the zebrafish are comprised 
of a glomerulus, PT, DT, and cloaca (Figure 3B,D). While the mammalian and zebrafish have 
differing numbers of nephrons, each nephron’s segmentation is well conserved (Figure 3A,B). For 
example, both the mammalian and zebrafish glomerulus express Nephrin, Podocin, and Mafb and 
are composed of podocytes with fenestrated barriers and capillaries to receive and filter blood into 
the nephron 4. Both the mammalian and zebrafish PT express variants of Na+K+ATPase to absorb 
the majority of the solutes and water prior to passing the filtrate through the rest of the nephron 4.  
  7 
 
Figure 3 Mammalian metanephric kidney and larval zebrafish pronephric kidney 
(A-B) Schematic segmentation sepecification of the nephron in mammals aunnd zebrafish.  The blood is supplied by 
the tuft of capilarries (red) which is then filtered through the glomerulus (Glom, green). The resulting filtrate moves 
through the entire nephron from left to right: proximal tubule further segmented into the neck (light green), proximal 
convoluted tubule (orange), and proximal straight tubule (orange); Loop of Henle (greys, only in mammals); distal 
tubule further segmented into tall ascending limb (blue), macula densa (magenta, mammals) or corpuscle of Stannius 
(magenta, zebrafish), distal convoluted tubule (dark purple), and connecting tubule (light purple, only in mammals); 
and collecting duct or cloaca (CD, black). (A) mammalian nephron. (B). zebrafish nephron. (C) Schematic diagram 
of the mammalian metanephric kidney and the orientation of the nephron within the kidney. (D) Schematic diagram 
of the zebrafish pronephric kidney.  
1.2 Acute kidney injury 
1.2.1 Definition, epidemiology, and classification 
Acute kidney injury (AKI) represents a disease spectrum with numerous contributing 
causes 21. It is defined as an abrupt decline in kidney function measured by change in serum 
creatinine level greater than or equal to 1.5 times baseline within 7 days 22. In the US alone, 577 
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experience AKI for every 100,000 persons and the incidence is higher in the hospital setting 1. In 
a hospital episode of care, 21.6% adults and 33.7% children experience AKI worldwide 23. Due to 
its prevalence, AKI presents very a heavy burden on the American health care system, costs 
ranging from $5.45 billion to $24.0 billion dollars in associated medical costs per year 24. 
Due to a wide range of causes, AKI is categorized via their anatomical references to the 
kidney: pre-renal, intrinsic, and post- renal. Pre-renal causes are processes in which the underlying 
kidney function is normal but the blood flow to the kidney is reduced 1. Intrinsic causes are 
processes in which there is a direct pathological issue to four major components of the kidney 1. 
The major components under duress include glomerular, interstitial, tubular, and vascular. One 
main example of intrinsic AKI is nephrotoxic agents, such as an aminoglycoside antibiotic 
gentamicin, which is actively transported into the renal tubular cells and disrupts phospholipids, 
releases ROS, and activates intrinsic apoptosis pathways 25 26. Post-renal causes comprise of those 
that result in blockage of urinary flow such as kidney stones or blood clots in the urinary tract 1. 
1.2.2 Risks and treatment 
Despite the research effort, AKI continues to be a problematic and concerning disease due 
to its increasing rate, rising from 600,000 cases in 2001 to 3.1 million in 2011, with an average 
mortality rate of 23.9% 27 28. Risk factors include the aging population, increasing cases of 
cardiovascular diseases, diabetes mellitus, pre-existing proteinuria, sepsis, and exposure to 
commonly prescribed medications during hospital stay such as NSAIDs and aminoglycoside drugs 
28. The above mentioned diseases, along with others such as shock, acute decompensated heart 
failure, pre-eclampsia, cardiac surgery, and cancer are contributing comorbidities that often put 
already hospitalized patients at a higher risk of developing AKI 28 27.  
  9 
Current established methods of care remain supportive. Few examples presented are: 
discontinuation of nephrotoxic agents and diuretics, radiocontrast procedures, and close 
management of patient volume status and perfusion pressure 29 30. The ultimate goal of these 
measures is to maintain hemodynamic stability and to avoid worsening of the damage that can 
potentially lead to irreversible loss of kidney function brought on by chronic kidney disease (CKD) 
or end stage renal disease (ESRD). Successful recovery from an episode of AKI is not always 
guaranteed 31 32. Upon irreversible injury, patients are moved from preventative measures to renal 
replacement therapy (RRT). Even with RRT, patients who undergo AKI suffer from a significantly 
higher short term and long term mortality and morbidity rates 27,33. Taken together, AKI is a 
prevalent condition that takes a heavy toll on millions of patients a year on a global level. 
Unfortunately, the lack of therapeutics to directly resolve the damage contributes to worsening of 
quality of life as well as a heavy toll on healthcare resources. 
1.2.3 Cellular pathophysiology 
AKI is a complicated condition due to various etiologies that lead to dysfunction of the 
kidney. The human kidney harbors at least 43 different cell types, each playing a critical role for 
homeostasis of the body 34. Therefore, it is not only important to understand the roles they play 
during homeostasis but also how they contribute to pathophysiology of AKI. The major cell types 
of interest that play an active role in the progression of AKI are: epithelial, vascular, interstitial, 
and immune components 20. Of those components, the next sections will focus on epithelial and 
immune components, the two major components affected in our model of AKI. 
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1.2.3.1 Epithelial component 
During an episode of AKI, the initial cellular injury observed in the kidney is the PT 20. 
The PT is particularly vulnerable to injury due to its critical and heavy role in reuptake of the 
majority of the filtered molecules, like glucose, amino acids, salt, water, as well as nephrotoxins 
35. The current knowledge in injury and repair mechanisms have been established using the 
mammalian models of AKI 20 36(Figure 4). Injury results in rapid loss of cytoskeletal integrity and 
cell polarity 37. These include loss and mislocalization of membrane proteins, transporters, cell 
adhesion molecules, such as Na+K+ATPase, tight junction, and adherens junction, respectively 20 
38 (Figure 4B). RTEC death and loss of adhesion weakens the barrier between the nephron and the 
interstitium of the kidney, resulting in permeability and backflow of the filtrate without proper and 
specific reabsorption, further creating systemic osmoregulatory problems 20 (Figure 4C).  
Multiple genes and proteins are differentially regulated in the injured kidney in humans 
and experimental models of AKI. In the injured PT, highly upregulated genes are: Kidney injury 
molecule-1 (Kim-1), Neutrophil gelatinase-associated lipocalin (Ngal), Tissue inhibitor of 
metalloproteinases 2 (Timp-2), and Insulin like growth factor binding protein (Igfbp-7) 38 39 40 41 
42. KIM-1 is a phosphatidyl serine receptor and is reported to participate in autophagy of injured 
RTECs as well as aid in leukocyte recruitment 43 44 39 45. NGAL, an iron-transporter, is another 
biomarker upregulated in the injury setting. It is known to form complexes with other iron-binding 
proteins, reduce superoxide formation and thereby subsequent cellular injury 46. More recently 
identified markers of injury are TIMP-2 and IGFBP7 47 41 42. They are proposed to induce cell 
cycle arrest and may serve as an earlier injury signal during an episode of AKI before the condition 
becomes irreversible 41. 
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1.2.3.2 Adaptive Repair 
Since renal biopsies are not often performed in AKI patients, the underlying repair physiology 
and histopathology have been largely defined using rodent models 48 49 . These studies have 
identified key cellular players during AKI events, including roles for the RTECs and the immune 
system. In steady state, the RTECs have approximately 1% baseline proliferation 50 51. At the onset 
of injury, however, the rate of cell cycle increases dramatically to replace the large number of lost 
cells due to necrosis and apoptosis 38 52. The enhanced population of RTECs are derived from 
surviving RTEC population that dedifferentiate, migrate along the basement membrane, proliferate 
and re-differentiate 53 54 52(Figure 4E,F). The differentiation process involves re-expression of 
mesenchymal genes normally expressed during development but silenced in developed kidneys, 
such as Neural cell adhesion molecule (Ncam) and Vimentin (Vim) 55 56 57 58 59 60 61. RTECs also 
express Sox9 and Pax2, which are developmentally critical genes for embryonic PT differentiation. 
During divisions, RTECs that co-expressed Kim-1, Vimentin, Sox9, Ki67 expand clonally, 
suggesting that a population of injured, dedifferentiating cells enter cell cycle and expand to 
repopulate the epithelium 62 52. The question still remains whether a select subpopulation of 
regenerative cells exists or all RTECs have the ability to stochastically initiate the repair 63 55.  
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Figure 4. RTEC cellular pathophysiology during AKI 
(A) Healthy, polarized proximal tubule RTECs express polarity-specifc proteins, such as basolateral Na+K+ATPase, 
adheren junction, and tight junction. (B) Upon injury to the PT, the cells initially lose epithelilal polarity, resulting in 
mispolarization of proteins mentioned above. (C) Cells undergo apoptosis (beige cell) necrosis (grey cell), expression 
of injury and inflammatory molecules such as Kim-1. (D) Cells delaminate off of the basement membrane (brown 
streaks) (E) Remaining cells undergo epithelial-mesenchymal-transition and reactivate developmental genes (flattened 
cells) such as Pax2, Sox9. (F) The reactivated cells proliferate and repopulate the damaged epithelium, expressing 
Ki67 or PCNA and redifferentiate into polarized epithelium 
1.2.3.3 Maladaptive repair 
It has been reported that only 26.6% of patients with an incidence of AKI will have 
sustained recovery 32. On the other hand, a large percentage of patients with AKI progress to a 
worsened, irreversible condition such as CKD or ERSD 32. This epidemiological study suggests 
that success of kidney repair is variable. The maladaptive repair is the result of a severe injury that 
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presents with marked inflammation and fibrosis 64 65. As such, there needs to be a deeper 
understanding of the molecular mechanisms that contribute to maladaptive repair. There are two 
cell types that undergo great transcriptional changes during AKI that contribute to the irreversible 
damage: the innate immune system and RTECs 66 67 36 20. The proceeding sections will expand 
further on RTECs and the innate immune system in the kidney and its roles in AKI and repair. 
RTECs play a heavy role in maladaptive repair by enhancing their pro-fibrotic factor 
expression, prolonged mesenchymal state, and prolonged interactions with the immune system. 
Injured cells express and secrete cytokines that will alert and recruit the innate immune system, 
such as monocyte chemotactic protein (Mcp-1), Tumor Necrosis Factor  (Tnf), Tissue Growth 
Factor--1 (Tgf-1) 67 68. This innate injury response is further exacerbated by cell cycle arrest. It 
has been shown RTECs that are arrested at G2/M phases of the cell cycle increase expression of 
profibrotic factors, Tgf-1, Connective tissue growth factor (Ctgf), and Platelet-derived growth 
factor b (Pdgf-b) 68. These factors enhance innate immune system activity and induce autocrine 
and paracrine effects on nearby RTECs. Tgf-1 drives epithelial to mesenchymal transition 
(EMT), a process that allows a polarized RTEC interacting with basement membrane in steady 
state, to undergo a transcriptional change to a mesenchymal phenotype 69. The mesenchymal cells 
gain heightened migratory capacity, invasiveness, and production of ECM components 69. The 
mesenchymal cells, as they sustain their profibrotic response, fail to differentiate and contribute to 
tubular atrophy 70 71. Studies have shown sufficiency and requirement of RTEC-specific Snai1 and 
Twist, two mesenchymal transcription factors, to worsen interstitial fibrosis and inhibit normal 
polarity and repair of the epithelium in mouse ischemia- reperfusion injury AKI (IRI-AKI) 72,73. 
EMT is also associated with RTEC cell cycle arrest. With Snai1 and Twist expression, the cells 
were more likely to undergo G2/M arrest 72 73. Conditional deletion of the two transcription factors 
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resulted in less cellular arrest in the mouse kidney and cell culture system 72 73. Another model has 
shown that Snai1 modulates various cyclins and checkpoint proteins to induce cellular arrest 74. 
1.3 Cell cycle behavior during AKI 
1.3.1 Cell cycle components 
RTEC cell cycle has gained interest as an early detectable biomarker of injury over markers 
that manifest after injury has gone too far 41 47. However, cell cycle dynamics and their effect on 
repair mechanisms in RTECs is not yet been completely understood. In eukaryotic cells, cell cycle 
is categorized into four phases, G1, S, G2, and M. Each phase is distinguished by specific 
molecular markers, cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase 
inhibitors (CKIs) that regulate progression through the four phases 75 (Figure 5). G1 starts with 
cellular growth, mRNA synthesis, and protein translation that is important for future cellular 
duplication 75. S is marked by DNA replication, in which cells become increase their DNA from 
2n to 4n, wherein n depicts the haploid DNA content of the genome 75. G2 is the second growth 
phase, marked with heavy protein synthesis for the cell to undergo division or M, mitosis 75. In M, 
the cell divides into two daughter cells. This phase is further subdivided into prophase, metaphase, 
anaphase, telophase, and cytokinesis. 
There are three major proteins that regulate entry into the cell cycle. Phase-specific cyclins 
(A, B, D, E) are upregulated in expression during their corresponding phase 75 (Figure 5). Cyclin-
dependent kinase (CDK) expression is less variable during phases, but their activity is dependent 
on interactions with phase-specific cyclins 75 (Figure 5). Phase-specific coupling of cyclins and 
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CDKs then activates downstream transcription of cell cycle related genes through a cascade of 
phosphorylation events of downstream target factors. In order to avoid errors in DNA replication 
or resolve DNA damage, cells utilize a braking mechanism to repair prior to division. This negative 
inhibition of cell cycling is controlled by the third type of modulator, phase specific CDK inhibitors 
(CKI). The CKIs are classified into two separate groups based on their targets: Inhibitors of CDK4 
(INK4) and CDK interacting protein/Kinase inhibitory protein (CIP/KIPs) 75 (Figure 5). INK4 
proteins inhibit CDK4 and thus inhibit the CDK4/6/cyclin D complex. CIP/KIPs exhibit a wider 
activity against other cyclins/CDKs 75 (Figure 5).   
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Figure 5 Cell cycle and associated cyclins, CDKs, and CKIs 
The schematic of 4 cell cycle phases, G1, S, G2, M (grey). Each phase is regulated by cycle specific activation of 
Cyclin/CDK complexes (red, green, blue, orange arrows), which then have downstream phosphorylation and 
transcription cascades required to transition to the next phase.  Cyclin expression is relatively unchanging (red, 
green, blue, orange lines) but the presence of CDKs are cell cycle specific. Upon damage, they are inhibited by CKIs 
(black text). G1 transition requires coupling and activation of CyclinD/ CDK4/6 (red) and subsequent Cyclin E/ 
CDK2 (green). This checkpoint can be inhibited by CKIs INK4 and CIP/KIP family proteins. S transition requires 
coupling and activation of CyclinA/ CDK2 (blue). This checkpoint is inhibited by CKIs, CIP/KIP. G2 transition 
requires coupling and activation of Cyclin A/CDK1 (blue). This checkpoint is inhibited by CKIs, CIP/KIP. M phase 
is regulated by Cyclin B/ CDK1 (orange) and are inhibited by CIP/KIP. 
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1.3.2 RTEC cell cycle under injury 
RTECs undergo a tightly regulated cell cycling mechanism. During steady state of a mature 
kidney, most cells rest at G0 and about 1% of the cell population will actively enter cell cycle to 
replace cells undergoing apoptosis or delamination via filtrate movement 76 50 75. In the setting of 
injury however, cells undergo active cycling and some become arrested by CKIs until repair occurs 
75. In experimental models of AKI, including ischemia reperfusion injury (IRI-AKI), aristolochic 
acid (AA-AKI) and gentamicin (gent-AKI), RTECs undergo DNA damage 67. DNA damage 
response (DDR) complexes are initial complexes that recognize DNA breaks and activate a 
downstream phosphorylation and transcriptional cascade to repair DNA. The two main DDR 
proteins are Ataxia telangiectasia mutated (ATM) and/or Ataxia telangiectasia and Rad3-related 
protein (ATR). They trigger downstream phosphorylation and transcription cascades that 
ultimately result in either apoptosis, necrosis, G2/M, or G1/S arrest.  
In DNA damage response, DDR factors activate CKI and induce arrest. Depending on the 
phase of arrest, G1, S, or G2, DDR factors interact with different cell cycle-specific factors and 
result in different gene profiles and variable recovery outcomes (Figure 6). Specifically, in G1, 
ATM recognizes the DNA break and phosphorylates the adjacent histone variant H2AX (H2AX 
or p-H2A.X), which then recruits other repair factors to the DNA break 77. At the lesion, ATM and 
Checkpoint kinase 2 (Chk2) are turned on to stabilize p53, which then induces transcriptional 
activation of a CKI, p21 78 (Figure 6). DNA damage induces p21 expression and it serves as the 
main brake from transitioning from G1 to S 79. During G1/S transition, cells express a series of 
Cyclin/ CDK coupling checkpoints, initiated by Cyclin D/ CDK4/6, then Cyclin E/ CDK2 79 
(Figure 6). These Cyclin/CDK complexes bind to p21 during injury, thereby halting the 
progression from G1 to S 79.  
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In G1, the cell cycle recovery, or release from G1 to S, is reversible 78. In G1 arrested cells, 
p21 imposes a cell cycle arrest by simply preventing the accumulation of Cyclin E/Cdk2 78 (Figure 
6). This step can be reversed by a phosphatase that deactivates cell cycle inhibitor components, 
which then allows re-accumulation of Cyclin E/ Cdk2 and a reversible transition to S-phase 78 
(Figure 5). This may be a reason why G1 arrest in the kidney has a positive effect during injury. 
In the kidney, halting G1 progression to S in the injury setting appears to result in a positive repair 
response. G1/S arrested RTECs expressed higher p21, followed by enhanced RTEC proliferation 
and AKI recovery 67 47. Other means of G1 arrest such as pharmacological inhibition of CDK2 
resulted in less severe nephrotoxicity 80. Pharmacological inhibition of CDK4/6, another 
checkpoint protein for G1/S transition, also resulted in enhanced repair 81 82 83. Conversely, p21-
deficient mice show more cells entering cell cycle due to unregulated checkpoints but ultimately 
result in more damage after injury due to unregulated cell division  cell death 84 85. Together, these 
results suggest that G1 induced arrest and increase in p21 activity enhance recovery by preventing 
propagation of genetic defects and preserving bio-energetically insufficient resources during 
duress of an injury 47. 
During the G2 arrest, the checkpoint is regulated by Cyclin A/CDK1 and Cyclin B/CDK1 
to assess whether the DNA replication and damage is resolved prior to cellular division 75 (Figure 
5, Figure 6). In G2, damage is recognized by ATM, Chk2, ATR, and Chk1 and these factors 
stabilize p53 and activate p21. This DDR cascade results in inhibition of CDK1/Cyclin B 78 (Figure 
6). Additional mechanisms of G2/M inhibition are p38 and TGF-, which also induce p21 
activation 86 (Figure 6). 
Cell cycle recovery from G2 to M is less likely. Compared to G1 arrest, p53 and p21 have 
additional functions in G2 arrest. In G2 arrest, p53 and p21 also drive transcriptional repression 
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and degradation of pro-mitotic genes and proteins, such as Cyclin A, Cyclin B1, and Plk178. 
Lacking such pro-mitotic transcripts and proteins prevents cell cycle recovery, or resumption of 
the normal cell cycle 87 88 89 90. Cells that retain G2 DNA profile but lack G2/M protein due to 
premature degradation are then committed to irrecoverable arrest and cellular senescence, 
secreting inflammatory cytokines, such as IL-1, IL-1, IL-6, IL-8, MCP-1, CCN2, and TGF-1 
91 92 93 88 94 90. G2/M arrest is associated with poor prognosis of AKI, suggesting the negative role 
it plays in maladaptive repair, potentially due to irrecoverable cell cycle arrest 71 67 95. RTECs 
arrested at G2/M have shown a significant increase in the production (?) pro-fibrotic growth 
factors, such as TGF-, Collagen 1, and CTGF 67 96 97 98. As discussed above, p21 protects RTECs 
from AKI in less severe models of AKI 99 100 85. However, as shown by the G2/M irrecoverable 
arrest, p21 serves a dual purpose in RTECs 95. In a more severe injury model of AKI to CKD, p21 
expression is detrimental as p21-loss of function mice showed enhanced renal repair 84. Overall, 
the G1 and G2 phase arrests are functionally distinct and have different implications for cell cycle 
recovery and survival following the induction of arrest. 
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Figure 6 DNA damage signaling in G1 and G2 arrest 
DNA damage response pathway varies between cell cycle due to presence of cell cycle machinery available during 
each checkpoint. In G1, ATM and yH2AX are activated. This allows further cascade of, Chk2, p53, and p21 activation 
that ultimately inhibits Cyclin D/ CDK4/6 and Cyclin E/ CDK2. In RTECs, non-DNA damage stressor can also induce 
arrest, such as TGF-, which also enhacnes transcription of p21 via unknown mechanisms. In G2, ATM and its 
downstream cascade is also active. Additional DDR  in G2 is ATR, which activates Chk1, p53, p21. In RTECs, non-
DNA damage stressors induce arrest, such as p38-MAPK and TGF-. They both enhance transcription of p21.  
1.4 Innate immune system activation in AKI 
1.4.1 Macrophages 
1.4.1.1 Origin and function 
After the initial insult to kidney tubules, both the damaged tubular cells and recruited 
immune cells release inflammatory factors. This initial damage response is critical for regenerative 
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capacity of the kidney, as well as other organs. Various models of AKI (i.e. sepsis, ischemia, 
nephrotoxins) all converge at a similar inflammatory response: increased expression of Damage-
Associated Molecular Pattern (DAMPs), Toll-like Receptors (TLRs) from damaged tubular cells. 
This response acts as a signal to recruit leukocytes, macrophages and neutrophils serving as the 
first line of defense. Macrophages were once viewed as a single population of phagocytic cells 
derived from one lineage from the bone marrow 101. However, later studies delineated two distinct 
lineages from which macrophages originate: embryonic and bone marrow-derived macrophages 
102. These two populations have varying roles not only during mammalian embryonic 
development, but also in response to injury in adults. In injury setting, the various lineages of 
macrophages play complex roles in injury response and resolution. In the ensuing sections, we will 
outline the various macrophage lines and their respective roles during development as well as 
during injury settings.  
The first population, known as embryonic macrophages, expresses the PU.1 transcription 
factor gene and is derived from hematopoietic stem cells within the yolk sac during embryonic 
development. Later in development, HSCs migrate from the yolk sac to the bone marrow, which 
then becomes the main site of hematopoiesis in mammals. The embryonic macrophages function 
in innate immune protection and regulate fetal architecture by promoting vascularization, clearing 
apoptotic cells, supplying cellular matrix components (laminin, type IV collagen, and 
proteoglycans), and providing cues for RBC maturation 103. Another crucial function for 
embryonic macrophages is to migrate to sites of developing organs and mature into various types 
of tissue-resident macrophages, such as the Kupffer cells in the liver. In each organ, resident 
macrophages have specific roles to maintain the steady state, including clearing cells undergoing 
apoptosis and engulfing cells to remodel tissue architecture during development. Over the course 
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of organism’s life, resident macrophages self-replenish and carry out immunosurveillance and 
organ-specific functions 104. 
With the onset of injury, the resident macrophage population is aided by the second lineage: 
the bone marrow-derived macrophages104. Both resident and recruited bone marrow-derived 
macrophages assume different phenotypes over the course of injury to initiate and prolong 
inflammation, increase phagocytosis, promote other immune cell recruitment, and ultimately 
resolve injury104. The ensuing sections will review known contributions of macrophages in each 
step of injury and resolution, as well as currently known pathways responsible for each 
macrophage subtype. 
1.4.1.2 Activation during AKI 
Much of our understanding of macrophage polarization in the AKI setting has been derived 
from injury models that recapitulate a few prevalent subtypes of AKI in human population. While 
various methods converge on damaged and dying RTECs, each source of damage exerts distinct 
initial damage to the kidney and thus different initial immune response. In IRI-AKI, endothelial 
cells are the first responders to the injury, immediately displaying signs of vasoconstriction 
expressing Endothelin-1, Angiotensin II, thromboxane A2, and adenosine 105 106. They directly 
stimulate leukocyte migration to the kidneys by increasing expression of ICAM-1, and the rest of 
the adhesion cascade, allowing endothelium-leukocyte interaction 38. In turn, lack of oxygen 
results in the neighboring RTECs expression of DAMPs and Hypoxia-inducible-factors (HIFs) 107. 
The RTEC response accompanied by increased vascular rarefaction results in facilitation of 
leukocyte migration and the initiation of early inflammatory response in the interstitium within 
24hrs of injury 108. Conversely, nephrotoxic AKI directly targets RTEC. Cisplatin, a widely used 
chemotherapeutic reagent, can bind to transporters such as Ctr1, OCT2 to translocate into RTECs 
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and induce DNA damage and inhibit protein synthesis 109. Cisplatin also plays a direct role in 
macrophage phenotype even when they are isolated from the kidneys. An in vitro study of cisplatin 
administration on murine peritoneal macrophages significantly increased pro-inflammatory 
cytokines and nitric oxide (NO) expression via the MAP kinase (MAPK) pathway 110. While this 
may explain the high injury severity typically associated with cisplatin-AKI, whether this is true 
in situ and is the cause of high cellular damage has not yet been concluded. Overall, not many 
studies compare macrophage responses among various models of AKI. Further elucidation of 
polarization mechanisms may lend insights into repair pathways unique to each subset and improve 
personalized therapeutics. The ensuing sections cover what is known to date, research mostly 
conducted in IRI-AKI.  
With the onset of injury, damaged RTECs release DAMPs and in sepsis AKI, pathogen-
associated molecular patterns (PAMPs), which act as an initial injury signal to sentinel immune 
cells within the tissue, such as resident macrophages and dendritic cells. Macrophages recognize 
the initial damage signals through pattern recognition receptors (PRRs), a family of receptors that 
recognize DAMPs and PAMPs. Recognition of DAMPs and PAMPs via PRRs results in 
downstream stimulation of macrophage phagocytosis, phagolysosome maturation, antigen 
presentation, and production of TNFα 111. These are important factors for further stimulation of 
innate immune system. 
After the initial recognition of injury, resident macrophages further prolong inflammation 
by recruiting other leukocytes to the site of injury. Among those recruited are neutrophils, bone 
marrow-derived monocytes and macrophages, and lymphocytes. Macrophage-derived chemokines 
and cytokines target different stages of leukocyte migration to increase recruitment. For example, 
TNFα, IL-1β, and histamines stimulate endothelial cells to increase expression of trafficking 
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molecules (selectins, integrin ligands), whereas chemokines CXC1, CXCL2, and CCL2, directly 
recruit neutrophils to extravasate from the circulatory system into the interstitium 112. The initial 
inflammatory macrophage events are subsequently followed by modulation and then inhibition of 
the inflammatory response. This phenotypic change, termed as macrophage polarization, occur via 
tissue-specific, complex pathways and will be delineated in the ensuing sections.  
1.4.1.3 Macrophage polarization 
The initial tissue macrophage and dendritic cell responses promote further inflammation 
via recruitment of other pro-inflammatory immune cells such as monocytes and bone marrow 
derived macrophages. Although derived from the bone marrow, monocytes and macrophages 
migrate and maintain a stable population in the spleen, a peripheral lymphoid organ that responds 
to injury signals and readily dispatches immune cells to the site of injury 113. The recruited 
monocytes differentiate into macrophages and dendritic cells at the site of injury. The recruited 
macrophages acquire a wide spectrum of phenotypes, from highly inflammatory to highly 
reparative and anti-inflammatory, as well as many intermediates. Traditionally, macrophages have 
been generally categorized into two populations: Inflammatory macrophages, called M1 or 
classically-activated, and anti-inflammatory macrophages called M2 or alternative macrophages.  
At the onset of injury, recruited macrophages become activated by LPS (under sepsis AKI), 
IFNγ, and GM-CSF released from the damaged microenvironment 114. In the kidney, M1 specific 
cytokines increase in expression within the first 24 hrs post injury and significantly decrease at 3 
days post injury 115. Upon activation, M1 macrophages secrete inflammatory cytokines such as IL-
1β, TNF, IL-12, IL-18, and IL-23 116 (Figure 7). As a result of these inflammatory cytokines, the 
site of injury continues to gain other inflammatory cells, including T helper cells 114. The M1 
macrophages also secrete molecules for destruction of pathogenic particles such as nitric oxide 
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generated by inducible nitric oxide synthase (iNOS).  Once pathogens or damaged cells are cleared, 
a rapid change in macrophage polarization is necessary to stop further damage to surrounding 
undamaged cells. Prolonged activation of inflammatory macrophages has negative effects in injury 
recovery, since the released cytotoxic agents do not discriminate self from pathogenic particles 
117,118. 
Various experimental models have concluded that prolonged inflammatory macrophage 
activation imposes negative consequences in injury resolution due to excessive inflammation. A 
study in the cardiovascular field reported that atherosclerotic lesions with a higher number of 
inflammatory macrophages correlated with higher likelihood for sudden major cardiovascular 
ischemia 119. In the kidney, perdurance of activated macrophages contributes to worse outcome 
after renal ischemia. Clodronate-induced depletion of all macrophages and then subsequent 
transplantation of IFNγ-stimulated M1 macrophages prior to renal ischemia resulted in more 
severe tubular damage 115. Furthermore, depletion of macrophages before injury reduced blood 
urea nitrogen levels and post-injury histological markers of tubular injury, whereas depletion 
during reparative stage resulted in significantly worsened injury markers 120. Taken together, these 
studies suggest that while the initial inflammatory response from macrophages is necessary for 
removal of damaged and pathogenic particles, prolonged inflammatory activity results in further 
tissue damage, ultimately inhibiting the reparative phase for injury resolution.  
M2 macrophages do not become activated until later in the initial injury phase. In an 
experimental IRI-AKI, an increase in M2 markers is observed at 3dpi, peaking in expression at 7 
dpi 115. M2 macrophages originate from newly recruited monocytes dispatched from the 
circulatory system, as well as initially recruited M1 macrophages 121. The phenotypic conversion 
from monocytes and M1 macrophages to M2 macrophages requires specific cytokine stimulation 
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and subsequent transcriptional changes. M2 macrophages are activated by macrophage- colony-
stimulating factor (M-CSF), IL-4, IL-10, IL-13, and TGF-β 114 (Figure 7). Upon activation, M2 
macrophages overexpress mannose receptor (MR), a receptor that will recognize and downregulate 
high levels of inflammatory glycoproteins previously produced by the inflammatory response 122. 
M2 macrophages also produce Arginase, an enzyme necessary to produce ornithine and 
polyamine, both building blocks for extracellular matrix architecture. Furthermore, M2 
macrophages secrete resolvins, lipoxins, TGF-β, and Matrix metalloproteinases that target and 
cleave chemokines and chemoattractants, resulting in inhibition of inflammatory immune cell 
activity 112. Over the past decade, alternative macrophages have been categorized into four 
subtypes based on their in vitro upstream activators and downstream gene expression patterns 123. 
M2a are activated by IL-4, IL-13, M2b are activated by IL-1, LPs, M2c are activated by IL-10 and 
TGF-β, and glucocorticoids, and M2d are activated by IL-6 and adenosine 123. Currently, only a 
few studies have investigated the origin of each subset using in vivo models and have described 
each subtype’s role in injury resolution.  
1.4.2 Neutrophils  
1.4.2.1 Origin and function 
Neutrophils arise early during development in a process called granulopoiesis. During 
granulopoiesis, hematopoietic stem cells (HSCs) invade the liver and produce erythro-myeloid 
progenitors (EMPs), which then differentiate into neutrophils during embryonic development 124. 
In later development phase, HSCs and EMPs migrate to bone marrow and continually generate 
neutrophils and other granulocyte lineages throughout adulthood 125. During steady state, 
differentiated neutrophils migrate in the circulation at a steady state of 40μm/s 126. They will 
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circulate and phagocytose cellular debris under steady state conditions by generating reactive 
oxygen species and matrix-modifying granule enzymes 127. Mammalian neutrophils consist the 
largest percentage of the white blood cell population, but they turn over quickly as the senescent 
neutrophils are cleared out by lymphoid organs such as the liver, spleen, and bone marrow 128.  
1.4.2.2 Activation in AKI 
In steady state, neutrophils travel in a slow-rolling motion in the circulatory system. 
However, at the onset of injury, they are able to recognize adhesion molecules expressed in 
endothelial cells during injury. Upon recognition of the injury-related integrins, neutrophils 
undergo a stepwise cascade of migration, ultimately migrating to the specific site of injury. The 
four phases must be activated in a stepwise fashion in order for normal neutrophil adhesion and 
infiltration. First, neutrophils are tethered and begin slow-rolling following interaction with 
specific selectins expressed by endothelial cells near the site of injury. Neutrophils express P-
selectin glycoprotein ligand-1 (PSGL-1), which reduces migration and allows more time for 
interaction with P-selectin expressed by endothelial cells. Second, upon activation of slow-rolling 
phase, neutrophils further increase affinity to endothelial cells by increased expression of platelet 
endothelial cell adhesion molecule (PECAM). This integrin interaction stimulates the firm 
adhesion of neuthrophils to the endothelial layer, which is required for effective extravasation from 
the circulatory system into the specific site of injury. Third, the final, neutrophil migration occurs 
along a gradient of chemokines and cytokines that are secreted by parenchymal and immune cells 
already present at the site of injury. Tissue-resident dendritic cells and macrophages, produce 
chemokines and cytokines (CXCL1, CXCL2, TNFα) 129 130, platelet activating factor, and 
complement fragments, allowing controlled and localized neutrophil migration 126. After the final 
migration step, the neutrophils are activated by a wide panel of factors released by a many cells: 
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mesenchymal stem cells, T cells, B cells, natural killer cells, macrophages, and dendritic cells. 
Together, the mesenchymal stem cells and various immune cells release five major types of 
cytokines: granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-
stimulating factor (GM-CSF), TNF, and Type I and II Interferons (IFN) 131. Upon activation, 
neutrophils increase production of effectors such as lytic enzymes, antimicrobial peptides, and 
neutrophil extracellular traps 131. Aside from the classically known effectors, neutrophils have 
recently been described to produce various cytokines that feedback on the other recruited immune 
cells. They produce CXC-chemokines, CC-chemokines, pro-inflammatory and anti-inflammatory 
cytokines, immunoregulatory cytokines, CSFs, angiogenic and fibrogenic factors, and TNF 
superfamily. Interestingly, in vitro data suggests neutrophils interact with monocytes and 
macrophages to inhibit their activation 132,133. However, in vivo, neutrophils may be indirectly 
stimulating macrophage activation by stimulating other immune cells, such as NK and T cells.  
Aside from influencing the function of other immune cells, neutrophils directly control the 
inflammatory reaction. Outside of the well-known inflammatory activity, recent studies have 
revealed a passive anti-inflammatory role neutrophil play towards the end of acute injury phase. 
During the final phases, neutrophils switch from the inflammatory eicosanoid leukotriene B4 
biosynthesis to the anti-inflammatory eiconsanoid (lipoxin A4). Neutrophils also synthesize 
resolvins and protectin D1, which are pro-resolving mediators that block neutrophil 
transendothelial migration and infiltration 131. More recent studies have identified neutrophil-
derived microvesicles that contain anti-inflammatory cytokines, such as TGF-β. However, these 
mechanisms are not sufficient for wound resolution- the neutrophil population must remove itself 
in order for further healing to occur. Neutrophil resolution usually occurs via efferocytosis, 
neutrophil apoptosis, or reverse track back to circulation 134 135 136 . Inhibition of each of these anti-
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inflammatory mechanisms resulted in prolonged inflammation as well as poor injury resolution137 
138. 
Like other wound healing models, neutrophils migrate to the site of damage after AKI in 
rodents and zebrafish. In various tissue injury settings, high neutrophil infiltration exerts negative 
consequences in resolving injury 139. Neutrophil specific secreted factors are correlated with worse 
prognosis. For example, high urinary NGAL-1 acts as a biomarker for worse prognosis in patients 
diagnosed with AKI 140. Recently, various studies focused on targeting neutrophil-associated 
pathways to inhibit inflammation during AKI and other injury models. For example, targeting 
factors important for neutrophil migration and activation (TLR2, TLR4, and Myd88) protected 
renal function and less inflammation in mouse model of sepsis 141. Neutrophil inhibition to injury 
sites limits exposure to phagocytosis, degranulation, oxidative burst, and cytokine production. 
Furthermore, neutrophils are precluded from recruiting further pro-inflammatory innate and 
adaptive immune cells. Some studies further explored whether improved regeneration is due to 
lowering neutrophil-derived inflammatory cascade. For example, Kimura et al. investigated the 
effects of neutrophil-derived IFN-γ, a pro-inflammatory cytokine, in repair after cisplatin-induced 
kidney injury. Mice with neutrophil-specific knockdown of IFN- γ showed improved repair by 
promoting RTECs autophagocytosis rather than prolonging inflammatory cytokine production 142.  
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Figure 7 Various pathways identified for macrophage polarization 
Experimental studies of several pathways have elucidated critical pathways for driving macrophage polarization from 
M1 to M2. Among them are IL-4/STAT6, JAK2/STAT3, CREB/C/EBP, and MEK1/2. Each macrophage phenotype 
has signature expression of certain cytokines and secreted products. M1 macrophages secrete inflammatory cytokines 
and products and chemoattractants, such as: IL-1, IL-6, IL-12, TNFa, iNOS, and ROS. M2 macrophages secrete anti-
inflammatory cytokines and pro-reparative secretions such as: Arginase, Resolvins, Lipoxins, Matrix 
metalloproteinases, TGF-, and Wnt ligands. *There seems to be tissue-specificity to types of Wnt ligands secreted, 
specifically Wnt7b in kidney macrophages and Wnt5a, Wnt 6, and 9a in intestinal macrophages. 
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M2 macrophage subsets are under scrutiny for both their ability to curtail inflammation 
before inducing further damage, as well as for their inherent reparative abilities. Saha et al. 
demonstrated that macrophages are crucial for normal repair after an acute injury to the intestines. 
The post-injury intestinal stem cells required macrophage-derived extracellular vesicles for 
increased proliferation and repopulation of damaged cells. The Wnt ligands, Wnt5a, Wnt6, and 
Wnt9a, were the main factors encased in the vesicles driving the repair 143. In lung injury, 
MAPK1/2 inhibition resulted in an increased M2 population, leading to better recovery weight and 
increased macrophage efferocytosis of inflammatory cells 144. In accordance with the preceding 
study, post-AKI repair also requires macrophage-derived Wnt for normal kidney repair. Lin et al. 
reported that kidney specific macrophages secrete Wnt7b, a canonical Wnt ligand. In depleting 
kidney-specific Wnt7b, the study showed Wnt7b is necessary for improved tubular repair, reduced 
fibrosis, and bypassing G2/M cell cycle arrest 145. 
1.5 Zebrafish as model organism 
1.5.1 General strengths of zebrafish 
The zebrafish (Danio rerio) has served as a very powerful tool for studying vertebrate 
biology, ranging from development, drug screening, to genetics. Over simpler models such as yeast 
and cell culture, zebrafish offers more complex vertebrate specific organs such as the kidney. With 
over 70% of the human genome conservation, the zebrafish genome annotation identified more 
than 26,000 protein-coding genes, as well as conservation of epigenetic processes such as DNA 
methylation, histone acetylation, non-coding RNAs 146 147. In contrast to more complex models 
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such as mice, the zebrafish offers visual access to ex utero development, less space and 
maintenance requirements, and high fecundity and short developmental time that allows high-
throughput studies 148 149. Ultimately,  zebrafish as a model organism contributed to large forward 
genetic screens that identified multiple genetic lesions contributing to previously unknown human 
disease syndromes 149 150. 
Zebrafish, unlike most vertebrate models, are able to regenerate their organ systems more 
efficiently, which makes them a perfect model for regenerative studies. While most vertebrate 
models have a few organs with regenerative capacity, the zebrafish can regenerate most of their 
organs, such as the heart, kidney, liver, fin, and spinal cord 151. The zebrafish’s regenerative 
capacity along with their genetic conservation to humans open possibilities for discovering 
mechanisms that can be applied to humans. Finally, the zebrafish community is in a constant move 
towards development of more advanced genetic tools. Such examples range from microinjection 
of constructs for successful germline transmission for transgenic fish generation, live cell lineage 
tracing, tissue-specific transgene expression, targeted cell ablation, heat shock inducible models, 
GAL4/UAS, CRE/LOXP, TETON/TETOFF, and fluorogen activating proteins  technology 151 149.  
1.5.2 Larval zebrafish model of AKI 
Not only is the zebrafish kidney developmentally and functionally conserved, but their 
response to AKI parallels that of the mammalian response. Multiple models of larval zebrafish 
AKI exist, including injection of nephrotoxins such as gentamicin and cisplatin, mechanical 
damage, and laser ablation 152. Nephrotoxin induced AKI consist of about 14-26% of AKI cases 
and therefore gentamicin-induced AKI (gent-AKI) is a clinically relevant model 153. Further, 
molecular hallmarks that occur in mammalian gent-AKI also occur in zebrafish 154 155 61. The 
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injection of gentamicin into the cardiac venous sinus of 50-70 hpf resulted in edema as well as 
glomerular and tubular distensions and obstruction due to cell death 154 155. Higher number of 
lysosomes were detected in the RTECs, a common hall mark in mammalian models of 
aminoglycoside nephrotoxicity 154. 10kDa dextran, a solute normally transported via RTECs, could 
no longer be filtered through RTECs post gent-AKI 154.  
In addition to RTEC functional changes, our group has shown structural and molecular 
changes that occur in both mammalian and zebrafish models. After gent-AKI, RTECs show loss 
of cell polarity, as seen by changes in Na+K+ATPase expression pattern and structurally flattened 
RTECs seen by H&E staining 156. Cells show increased death as shown by increased terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). Injury accompanies reactivation 
of developmental genes such as Pax2a and RA response elements (RARE) 157 158. The cell cycle 
was also affected, with injured RTECs showing increased population of cells that incorporate 5-
Ethynyl-2´-deoxyuridine (EdU), a thymidine analog that captures cells undergoing the S-phase. 
This model of AKI results in between 50-80% death after about 7dpi, due to worsening renal 
function and systematic failure 154. The larval model of gent-AKI offers a short but clear window 
of the early injury response. Therefore, this method serves as an excellent model to test candidate 
drug post-injury and observe their efficacy for early injury prevention.  
1.5.2.1 Development recapitulation during injury  
As seen in mammals, zebrafish also reactivate renal developmental genes in RTECs during 
AKI. First, Pax2a, is an important regulator of glomerulus and PT specification 159. It is a DNA 
binding, transcription factor required for kidney development 159. It has been proposed that Pax2 
interacts with methyltranferase complexes, such as Ptip (Pax transactivation domain interacting 
protein) or Grg4 (Groucho-related gene4) to regulate histone methylation and subsequent 
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expression of various genes necessary for renal development 160 Its earliest expression is detected 
in the developing renal progenitor cells in the IM 159. In zebrafish, specifically, it is proposed to 
inhibit podocyte formation and enhancing proximal segment specification. Lack of pax2a results 
in over-expression of wt1a transcripts that results in inhibition of the PT segment 161. Without 
pax2a expression, the segments fail to become polarized, losing polarity-specific proteins such 
Na+K+ATPase that marks basolateral membrane of RTECs 161.  
Another developmental pathway of interest is the RA signaling pathway. RA is important for 
specification of caudal and rostral segments of the zebrafish pronephros 3. Genetic or 
pharmacological disruption of RA signaling in zebrafish embryos result in lack of segmentation, 
with preferential development of the DT over the glomerulus and PT 16 162. Conversely, enhanced 
RA signaling via exogenous treatment results in preferential development of the glomerulus and 
the proximal tubules over distal segments 162 163 16. Specifically, in the glomerulus, there is in vivo 
evidence of RA directly affecting its specification by activating RA receptor (RAR) and retinoid 
receptor (RXR) to induce wt1a transcription 164. Blocking RA signaling results in prevention of 
two glomerular transcription factors wt1a and odd skipped related-1 (osr1) 165. Although the 
developmental mechanisms and sources of RA are well delineated, the question of how RA affects 
the kidney regeneration in AKI setting is unclear. RA is enhanced in the PT early on during the 
nephrotoxin injury model within 12hpi 157. RA activity is also observed in macrophages that 
infiltrate the mouse kidney 157. Mammalian models of AKI have shown that RA treatment 
attenuates injury and facilitates recovery by inhibiting apoptosis in various models 166 3. However, 
the source of synthesis and degradation of retinoids and how and which cell type responds to the 
final bioavailable RA still remains unknown.  
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1.5.3 Zebrafish as model organism to study innate immune response 
Studies have revealed that both mammalian and zebrafish HSC share conserved 
mechanisms of myelopoesis during embryonic development. As in mammals, there are two waves 
of HSC migration and differentiation in the zebrafish, termed primitive and definitive 
myelopoiesis. The primitive myelopoiesis occurs between 12-48hpf, when various precursor cells 
initiate differentiation and produce mature cell types from mesodermal tissue along the notochord 
167. The second wave, called definitive myelopoiesis, occurs when HSC migrate and seed in the 
anterior segment of the pronephros. The migrated HSC remain as the definitive pool of self-
renewing cells that continue to produce mature leukocytes from 4dpf larvae to adulthood 167 168. 
There are key regulatory factors that are shared between mammalian system and zebrafish that 
allow macrophage differentiation. For example, pu.1, spi-b, and irf8 are required for macrophage 
development in zebrafish as they are required for mammalian macrophage differentiation 169  
While mammalian and zebrafish myelopoiesis is conserved, very few in situ studies have 
examined zebrafish M1 and M2 macrophage markers. A recent study has shown live imaging of 
macrophage polarization in fin amputation, using transgenic reporter for tnfa and mpeg1, a 
macrophage marker 170. While additional in situ studies are necessary to confirm other markers for 
zebrafish macrophages, there is evidence that mammalian and zebrafish polarization events are 
evolutionarily conserved. Many of mammalian markers that appear during macrophage 
polarization are orthologues upregulated in zebrafish injury settings, like pattern recognition 
receptors, IFN-γ, iNOS, TNFα, GM-CSF.  
Acute immune response is often associated with worsened outcome in human injuries. In 
studying regeneration to model these injuries in fish, it is imperative to also characterize their 
immune response. So far, the zebrafish larvae have served an important role in characterizing 
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macrophage and neutrophil migration, and in vivo imaging of macrophage polarization171 170. So 
far, studies have characterized specific factors required for macrophage interplay with various 
disease states such as myocardial infarction, fin, and liver regeneration 172 173 174. Furthermore, 
recent fin amputation studies have demonstrated that macrophage polarization is a conserved 
phenomenon in zebrafish. Using a transgenic line, Nguyen-Chi et al. visualized by in vivo imaging 
activation and subsequent repression of pro-inflammatory (TNFα) gene in macrophages recruited 
to the site of injury. TNFα+ macrophage recruitment was observed as early as 1hr post amputation, 
while TNFα- macrophage recruitment occurred at approximately 25 hrs post amputation. This 
study fully captures the advantage of utilizing zebrafish to elucidate unknown questions that have 
previously been deemed as difficult. The convenience of generating transgenic line paired with 
powerful imaging tools resulted in tracking macrophages in vivo, enabling characterization of 
M1/M2 velocity, contact frequency, and morphological changes 170. Taken together, the zebrafish 
larva has the potential to serve as a good model organism to elucidate the effects of macrophages 
in repair mechanism. 
1.6 4-phenylthiobutanoic acid (PTBA) 
1.6.1 Origins of PTBA 
Despite advancements in understanding AKI pathophysiology, there is still an unmet need 
for therapeutics for renal recovery. No targeted clinical treatments can accelerate renal recovery 
or decrease fibrosis. We previously identified 4-phenylthiobutanoic acid (PTBA), a novel short-
chain carboxylic acid class histone deacetylase inhibitor (HDI), which is considered class I HDAC-
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specific 148 175. The initial screening assay investigated the effect of PTBA in the expansion of 
embryonic renal progenitor field of zebrafish in the intermediate mesoderm of 10-somite embryos 
148 (Figure 2). Upon treatment, PTBA expanded the number of lhx1a, pax2a, and pax8 positive 
cells within 10-somite embryos, persisting to later stages of development after pronephric tubule 
development 148. The efficacy of compounds required the presence of actively proliferating cells, 
as blocking cell division resulted in loss of PTBA-induced proliferation 148. de Groh et al. 
examined the necessity of the RA pathway in expanding the progenitor cells 148. Depletion of Rara 
resulted in loss of lhx1a progenitor pool expansion 148. Overall, early experiments of PTBA during 
development suggests the compound enhances RPC population in a proliferation dependent 
manner and requires an intact RA signaling pathway.  
1.6.2 PTBA treatment in AKI 
The earlier studies on PTBA and its effect on kidney development implicated its potential 
strength as a therapeutic for post AKI repair. PTBA (UPHD20) was redesigned into prodrugs such 
as m4PTB (UPHD25), a PTBA methyl ester that is better absorbed and still metabolized into 
pharmacologically active form after administration 176. Metabolism studies showed UPHD25 was 
metabolized into PTBA in the kidney and liver of mice and had the same regenerative capacity 176 
(Figure 8). Using prodrugs, histological, functional, transcriptional responses of PTBA were 
quantified in various models of AKI, both in mice and zebrafish. All studies treated animals with 
PTBA after AKI has already occurred, a likely scenario in the clinic. Cosentino et al. first utilized 
the larval zebrafish gent-AKI in order to establish the mechanism of repair during PTBA treatment. 
2 days after injury, injured fish treated with PTBA showed significantly improved survival 156. 
Additional mouse studies gave further insights into long term effects of PTBA treatment. Post 
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injury treatment with PTBA showed lower renal fibrosis and enhanced renal function, quantified 
via blood urea nitrogen and serum creatinine levels. At cellular level, PTBA treatment resulted in 
lower Kim-1 expression, macrophage infiltration, overall reduced inflammation 177 176.  
 
 
Figure 8 PTBA prodrug metabolism 
Upon UPHD25 (m4PTB) treatment, the compond is metabolized by endogenous esterases, therby becoming an 
active parent compound, UPHD20 (PTBA). UPHD25 acts as a prodrug for more efficient delivery of the parent 
compound.  
 
PTBA’s target has remained elusive, but its structure suggested its role as a class I HDI 178. 
PTBA’s structure is characterized by: a warhead, the moiety binding zinc and inhibiting HDAC 
activity; linker and cap, moieties that bind to HDAC amino acid residues to contribute to selectivity 
178. Further function of the compound was validated using in vitro and in vivo assays to measure 
hyperacetylation of the histone H4148 179. While the hyperacetylation assay narrowed PTBA’s 
function as an HDI, its target still remained elusive as multiple HDACs affect developmental 
processes beyond the epigenetic mechanisms. Many HDIs are known to associate with cell cycle 
changes. Various class 1 HDIs are used to inhibit cell cycle. Some primary examples are 
Vorinostat, SAHA, class 1 HDIs, used for anti-proliferative and pro-apoptotic activity in cancer 
metastasis models 180. The cell cycle dynamics were changed with PTBA treatment. Zebrafish 
RTECs showed increased EdU-positive cells when treated with PTBA 156. Novitskaya et al. 
showed PTBA treatment increased the number of actively cycling RTECs and decreased phospho-
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histone 3 (pH3) positive cells at 14dpi, suggesting a potential role in decreasing G2/M arrest 177. 
A microarray analysis of PTBA-treated mouse kidneys revealed a decrease in cellular metabolism 
and an increase in cell cycle and microtubule-based processes 177. While various HDIs are shown 
to modulate cell cycle, many target multiple HDACs in nonspecific ways, which can cause 
unwanted side effects 180. Therefore, it is important to assess each HDAC in class 1 for their role 
in cell cycle modulation and clearly define their role in disease progression in the context of AKI. 
Taken together, these studies show PTBA enhances repair after AKI. However, the question still 
remains to which member of the family class 1 HDAC does PTBA bind and how the inhibition 
imparts its reparative capacity.  
1.7 Histone deacetylase 8 
1.7.1 General knowledge 
HDACs are categorized into four classes, based on structural similarities, cofactor metals 
required to activate the enzymes, and cellular localization, ranging from class I, IIA, IIB, III, and 
IV.  Members of class I include HDAC1, 2, 3, and 8. HDACs were originally found to deacetylate 
lysines of histones, acting as epigenetic modifiers. Gene expression is repressed when HDACs 
remove an acetyl group from a lysine, a positively charged amino acid, thereby enabling the 
chromatin to wrap tightly around histones and repressing gene transcription 181 182. Recently, 
HDACs have been scrutinized for their non-histone targets, driving post-translational 
modifications in a wide range of proteins that affect numerous cellular functions. 
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HDAC8 is unique in many ways when compared to class I HDACs. In humans, it is a 
protein of 42kDa, composed of 377 amino acids and is found in multiple organs including the 
heart, lung, kidney, and pancreas 183. HDAC8 does not have the conserved c-terminus protein 
binding domain found in other class I members 180. Without the conserved c-terminus binding 
domain, HDAC8 is the only cofactor-independent class 1 member 180. Another unique property of 
HDAC8 is its localization to both the cytoplasm and the nucleus. HDAC8 associates with many 
different proteins, including Structural Maintenance of Chromosomes 3 (SMC3), Estrogen 
Receptor Related alpha (ERRα), p53, Cortactin, and Alpha tubulin 180 184. Pathway enrichment of 
proteins predicted to associate with HDAC8 suggest its downstream roles in chromosomal 
stability, cell cycle, and cell motility 185 186. HDAC8 has been recognized for its roles in 
craniofacial and neural development, and Schistosoma mansoni parasite locomotion 187 188 189.  
1.7.2 HDAC8 in development and disease 
One of the most well studied disease associated with HDAC8 is Cornelia de Lange 
syndrome (CdLS), a craniofacial neural abnormality attributed to cohesin dysfunction. Multiple 
genes are attributed to this defective developmental syndrome, including HDAC8, NIPBL, SMC3, 
SMC1, RAD21, which all play roles in various different aspects of cohesin-associated processes, 
a ring-like complex that hold sister chromatids together during the cell cycle process 190. Cohesin 
is a multi-function complex that affects gene transcription, enhancer-promoter interaction, cell 
division, cell cycle check points. HDAC related craniofacial development mechanistic studies 
showed that HDAC8 can also post-transcriptionally repress downstream genes to suppress normal 
development of skeletal structures 182. 
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Although the HDAC8 expression was first discovered and characterized in the human 
kidney, it has recently been gaining attention as a target of interest in the field of AKI 183. Inhibition 
of HDAC8 suppresses inflammatory and fibrotic responses in various models of acute injury. One 
example of the fibrotic response mediated by HDAC8 is AKI-related renovascular hypertension 
followed by cardiac remodeling, hypertrophy, and fibrosis 191 192 193. Renovascular hypertension 
has been reported to induce specific HDACs in the left ventricle of the mouse heart, one of them 
being HDAC8 191 193. HDAC8 expression is associated with genes linked with fibrosis, such as 
Tgf-b and Ctgf 191 193. When HDAC8 activity is pharmacologically inhibited, fibrosis is 
significantly lowered in the heart 191 193 Prolonged epithelial-to-mesenchymal transition has been 
cited to increase fibrosis in the kidney, which results in increased expression of pro-inflammatory 
and fibrotic factors such as TGF-1 and CTGF 194. HDACs has been implicated in heightening the 
EMT process to fibrosis. Non-selective class I HDI such as TSA and MS-275 were used to inhibit 
Collagen1 and Fibronectin expression while maintaining E-cadherin in HK2 cells 192. Likewise, 
HDAC8-specific inhibition via siRNA resulted in suppression of mesenchymal phenotypes, 
Collagen, Fibronectin, and N-cadherin expression, while maintaining of E-cadherin integrity 192. 
A recent study showed that RTEC-specific HDAC8 expression as a culprit for renal interstitial 
fibrosis 195. In unilateral ureteral obstruction-AKI (UUO) and PT cell culture model, inhibition of 
HDAC8 resulted in lower fibrosis along with downregulation of EMT, G2/M cell cycle arrest, 
TGF-1, Smad3, STAT3, -catenin, and Snai1 195. 
Although HDAC8 specific mechanisms controlling EMT and fibrosis are not readily 
understood, pan-class I HDAC inhibitors downregulate E-cadherin by changing epigenetic 
environment of Id2 and BMP7, genes that are known to antagonize the fibrotic effects of TGF-1 
196 197. In a model of acute LPS-induced neuroinflammation, HDAC8 acts as a culprit in 
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inflammatory activation. LPS induced expression of pro-inflammatory factors, such as COX-2/ 
iNOS, TNF, was negated by a pharmacological inhibition of HDAC8 via WK2-16 198. Upstream 
analysis suggested HDAC8 inhibition suppressed STAT1/3/Akt activation, thereby reducing pro-
inflammatory response while enhancing repair response 198.  
1.7.3 HDAC8 in cell cycle and beyond 
Because HDAC8 is known to have various non-histone protein targets, it would be critical 
to examine its roles beyond epigenetic targets. One of highly regulated processes after AKI is 
increased cell cycle progression and check point regulation 199 75 65 95. There have been many 
studies pointing to HDACs acting to regulate cell cycle checkpoints, but the exact mechanism still 
has not been elucidated. A study of global HDAC substrate interactome using affinity purification 
coupled to mass spectrometry based proteomics found that HDAC8 has a distinct interactome 
profile when compared to other class I HDACs 185. HDAC8 is associated with the cell cycle 
regulators, Structural maintenance of chromosomes 1A (SMC1) 185 200 201 202 (Figure 9). 
As HDAC8 strongly interacts with the cohesin complex it is worth scrutinizing the 
downstream effect the cohesin ring may have on cellular functions. One of the functions of the 
cohesin complex is to facilitate normal cell cycling. The cohesin complex is comprised of four 
subunits that form a ring-like complex, SMC3 and SMC1 forming a hinge domain of the ring, and 
RAD21 cohesin complex component and STAG2 202 186 203 201. The assembled ring is then shuttled 
on and off chromatin throughout the cell cycle via specific enzymatic activities. In G1, the cohesin 
is loaded onto a 2N chromatid via Nipped-B-Like Protein (NIPBL)/ MAU2 chromatid cohesion 
factor homolog (MAU-2) complex 186 (Figure 9). During the DNA replicative S phase, the 4N 
sister chromatids are stabilized by the cohesin ring when it is conformationally locked by 
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acetylation of SMC3 via Establishment of Sister Chromatid Cohesin n-acetyltransferase2 
(ESCO2) 186 (Figure 9). During M, specifically during the separation of sister chromatids 
(anaphase), the ring must be dissolved by PDS5/Wings apart-like protein homolog (WAPL) 
mediated conformational change 186(Figure 9). At the end of M, HDAC8 deacetylates the 
dissociated SMC3Ac to be recycled to the conformationally steady state, unacetylated SMC3 186 
(Figure 9). Dysregulation of cohesin loading results in destabilization of normal cell cycling 186. 
SMC3 deacetylation is imperative for recycling of cohesin so that it can be reloaded during 
interphase for mitotic functions 186. Pharmacological inhibition of HDAC8 using PCI-34052 
resulted in accumulation of SMC3Ac delayed cell cycle progression at G0/G1 and suppressed 
proliferation 186. Other studies also confirmed HDAC8 inhibition increases G0/G1 cell cycle length 
in HeLa and HEK cells 184.  
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Figure 9 HDAC8 and cohesin complex during cell cycle 
Model for HDAC8, SMC3, and cell cycling interaction. Cohesin loading: Cohesin ring is loaded onto 2N during 
G0/G1 (green)  via interphase regulators,  NIPBL and MAU. Cohesion establishment: During S-phase (purple), DNA 
replication occurs. Acetylation of SMC3 is required for cohesion locking to establish sister chromatid cohesion. The 
acetylation of SMC3 (K112&K113) occurs via acetyltransferase, ESCO1/2. Cohesion establishment: Cohesion 
continues to be maintained in order to recruit repair proteins in presence of DNA damage up to G2 (yellow). Cohesin 
dissolution occurs during Mitosis (yellow) via separase in order to separate sister chromatids. The conhesin ring is 
dissolved into two parts, SMC3/1 and RAD21/STAG2. The freed SMC3AC must be recycled to be used for the next 
round of cell cyle via HDAC8 removal of acetylation at K112/K113. The newly deacetylated SMC3 is then reused 
for cohesin loading.  
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The cohesin ring has multiple roles and is directly implicated in DNA repair as well as 
transcriptional regulation through various mechanisms. HDAC8 colocalizes with RAD51 and 
SMC3 at sites of homologous recombination after double stranded breaks in the DNA, suggesting 
its role in aiding genomic stability after cellular injury 204. Transcriptionally, the cohesin has 
diverse mechanisms on regulating gene expression. With its ring-like structure, the cohesin 
complex can lend dynamic chromatin folds resulting in activation or repression of genes. It can 
stall RNAPII binding, activate enhancer and promoter looping, V(D) J recombination, and 
repression through enhanced chromatin looping 205 
Furthermore, the cohesin complex has been shown to be dynamic in locomotion, readily 
sliding through chromatin, complicating its role in gene regulation 206. The cohesin complex has 
been shown in various models to be important for developmentally critical phenomena, EMT and 
mesenchymal-to-epithelial (MET) transitions. In breast cancer, the cohesin ring loops and isolates 
TGF-1 and ITGA5 transcription start sites, inhibiting RNAPolI from binding and initiating 
transcription 207. Without TGF-1 and ITGA5 expression, cells are inhibited from initiating EMT. 
Conversely, knockdown of a cohesin ring component results in high transcriptional activity of 
EMT-related genes, driving mesenchymal phenotype. Not only is the cohesin complex critical for 
EMT/MET, it is also critical for transcription important for embryonic development. Zebrafish 
maternal to zygotic transition of transcription is partially carried out by active cohesin 
redistribution to active areas of the genome 208.   
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2.0 Elucidating mechanisms of PTBA in enhancing post-AKI recovery 
2.1 Hypothesis 
In an effort to identify pro-regenerative therapeutics for AKI, de Groh et al. utilized 
developing zebrafish embryos to screen for compounds that allowed expansion of renal progenitor 
cells within the intermediate mesoderm 148. The study identified 4-phenylthiobutanoic acid 
(PTBA), a histone deacetylase inhibitor (HDI), that allowed expansion of renal progenitor cells 
(RPC) during larvae development 148. Developmental pathways are often reactivated in the setting 
of injury. In the kidney, factors necessary for kidney formation such as Pax2 and RA signaling 
pathway are turned on in RTECs 159 209 210 98 157  16 162. Compounds that can enhance this 
development process may also be able to enhance reactivation of such pathways in injury setting. 
PTBA and its analogs have shown to be effective beyond embryonic development and also 
enhance survival rates in both zebrafish and mice models of AKI 148 156 177 211. Further long-term 
follow-up studies using IRI-, AA-, UUO- AKI collectively showed lower interstitial fibrosis and 
enhanced renal function, as measured by serum creatinine and blood urea nitrogen levels 176 177 156. 
While PTBA enhanced recovery outcomes, none of the cellular mechanisms driving recovery have 
been elucidated so far. Here, the study focuses on zebrafish AKI assays, as this model organism 
allows precise delivery of compounds, high throughput screening assays, and heat shock inducible 
models of interest. I hypothesize that PTBA treatment enhances AKI repair mechanisms via 
activating renal development processes to increase dedifferentiation and repair of RTECs, thereby 
attenuating injury.  
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2.2 Results 
2.2.1 PTBA increases dedifferentiation and proliferation post-AKI 
We have previously shown that PTBA treatment increases RTEC proliferation in a 
zebrafish larval model of AKI 156. To assess whether PTBA increases the population of cells that 
show AKI mediated reactivation, we examined whether post-AKI UPHD25 treatment increased 
expression of Pax2a, a critical early developmental transcription factor reactivated in RTEC during 
AKI 58 212 60 213. Larvae were injected with gentamicin (gent-AKI) between 78-82hpf, followed by 
a single-dose of UPHD25 treatment at 2 days post injection (dpi) (Figure 10A). We used the 
Tg(PT:EGFP) line, a transgenic line marking specifically PT of the zebrafish pronephros 156. In 
uninjured larvae, UPHD25 treatment had no significant effect on Pax2a reactivation (Figure 
10B,C,F). In gent-AKI larvae, Pax2a was reactivated in RTECs within 48hrs after gentamicin 
injection and expression is maintained in a population of RTECs through at least 3dpi (Figure 10D-
F). When gent-AKI larvae were treated with UPHD25, the number of Pax2a-positive RTECs 
significantly increases in both immunofluorescence assay and in transcript levels (Figure 10D-F, 
Figure 12). Results suggest that UPHD25 drives dedifferentiation of RTECS exclusively in an 
injury setting. To demonstrate that Pax2a is expressed in proliferating cells in zebrafish larvae in 
AKI, as has been shown in murine models, we co-stained for Pax2a and Proliferating cell nuclear 
antigen (PCNA), which marks cells in S, G2, M-phase, to show increase in cell cycling 212. Both 
UPHD25 and DMSO-treated larvae show double positive cells, but UPHD25 treated fish exhibit 
higher number of double positive cells than DMSO treated fish. (Figure 10G-I). Results suggest 
that UPHD25 increases RTEC reactivation and proliferation in injury setting. 
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Figure 10 PTBA treatment increases Pax2a reactivation and proliferation during AKI  
(A) Experiment schematic: Tg(PT:EGFP) larvae were injected with gentamicin at 3dpf to induce AKI (gent-AKI). At 
2dpi, gent-AKI larvae were treated with 1% DMSO or 1μM UPHD25 for 24hrs (2-3 dpi) then harvested for analysis. 
(B-E) Immunofluorescence staining of Pax2a (red), proximal tubule (PT, green), and nuclei (DAPI, blue) of age-
matched 6dpf no injury+DMSO (B), 6 dpf no injury+UPHD25 (C), 3dpi gent-AKI+DMSO (D), and 3dpi gent-
AKI+UPHD25 (E) larvae. Nuclear localization of Pax2a was shown by overlaying with nuclear counterstain, DAPI 
(blue). PT is outlined in white and Pax2a+ RTECs are marked with arrows. (F) Quantification of Pax2a+ cells. Data 
pooled from 3 biological replicates are shown expressed as mean+/-SEM. One-way ANOVA (G-H) 
Immunofluorescence co-stain of Pax2a (green), PCNA (red), and DAPI (blue) in gent-AKI+DMSO (G) and gent-
AKI+UPHD25 (H). Nuclear localization of PCNA was shown by overlaying with nuclear counterstain, DAPI (blue). 
Pax2a+ are marked with asterisks and PCNA+ are marked with arrows. (I) Quantification of Pax2a+ PCNA+ cells. 
Data pooled from 3 biological replicates are shown expressed as mean+/-SEM. Two-tailed t-test: *p<0.05, **p<0.01, 
n.s. = not significant. Scale bar= 20μm. 
2.2.2 PTBA increases dedifferentiation and ameliorates injury 
To confirm that Pax2a reactivation is associated with dedifferentiation of RTECs, we 
examined the effect of PTBA on Vimentin expression, an intermediate filament protein that 
increases in dedifferentiated RTECs after AKI 55. We treated gent-AKI Tg(PT:EGFP) fish with 
DMSO or UPHD25 at 2dpi and examined co-expression of Vimentin and Pax2a. Uninjured larvae 
did not show Vimentin nor Pax2a staining, while gent-AKI zebrafish showed Vimentin expression 
in Pax2a-positive cells (Figure 11A-C). Gent-AKI+UPHD25 zebrafish showed significantly 
increased Vimentin expression than in gent-AKI+DMSO treated zebrafish in immunofluorescence 
quantification (Figure 11C-D). As further evidence that dedifferentiation is enhanced with 
UPHD25 treatment, RNA-seq transcriptome profiling revealed a down-regulation of known 
epithelial markers and up-regulation of mesenchymal markers with UPHD25 treatment in injury 
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(Figure 12B,D). Together with an increased expression of Pax2a and Vimentin, this further 
validates the observation that UPHD25 treatment enhances dedifferentiation in RTECs. 
 
 
Figure 11 PTBA increases dedifferentiation during AKI  
Immunofluorescence co-stain of Vimentin (red, cytosolic) and Pax2a (green) in PT of age-matched 6 dpf no injury 
(A), 3 dpi gent-AKI+DMSO (B), and 3 dpi gent-AKI+UPHD25 (C). (D) Quantification of Vimentin+ RTECs. Pax2a+ 
are marked with asterisks and Vimentin+ RTECs are marked with arrowheads. PT is outlined in white. Data pooled 
from 3 biological replicates are shown expressed as mean+/-SEM. One-way ANOVA: ****p<0.001. Scale bar= 20 
μm 
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Figure 12 PTBA increases mesenchymal markers and lowers kim-1 expression  
6dpf Tg(PT:EGFP) larvae were used to collect 70-100 GFP+ pronephros of gent-AKI+DMSO, (AKI+DMSO) and 
gent-AKI+UPHD25 (AKI+UPHD25) at 3dpi. RNA was extracted then sequenced. Transcript expression for (A) 
pax2a, (B) vimentin, (C) havcr1 (kim-1). All graphs were generated using transcripts -per-million (TPM), log2-scale. 
All treatments were replicated (N=3). Each dot represents a biological replicate (grey) and the mean of total replicates 
(black). (D) Heatmap of RNA-seq expression levels of a panel of marker genes known to be critical in epithelial-to-
mesenchymal (EMT) transition. Each column represents one biological replicate.  
 
Since treatment increases the dedifferentiation and proliferation of proximal tubule cells, 
we examined the effect of PTBA on levels of kidney injury molecule-1 (Kim-1) expression, which 
increases in injured RTECs after AKI and also is associated with increased fibrosis and leukocyte 
recruitment 156 214 215. Following gent-AKI in zebrafish larvae, robust Kim-1 staining is detectable 
in injured fish by 2dpi 157. To quantify Kim-1 protein, we measured the percent area of fluorescence 
within the tubule as well as the transcript levels, shown by the RNA-seq data (Figure 12C, Figure 
13A-D). Compared to gent-AKI+DMSO, gent-AKI+UPHD25 zebrafish showed a lower 
expression of renal Kim-1 expression at 3dpi (Figure 12C, Figure 13A-D). Collectively, data 
demonstrate that Pax2a reactivation occurs in dedifferentiated RTECs after gentamicin injury, and 
that PTBA mitigates cellular injury in RTECs.  
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Figure 13 PTBA decreases Kim-1 expression level after AKI 
Immunofluorescence of Kim-1 expression in age matched (A) 6dpf uninjured, (B)3dpi gent-AKI +DMSO, (C)3dpi 
gent-AKI +UPHD25 (C) larvae. Apical localization of Kim-1 was shown by overlaying with nuclear counterstain, 
DAPI (blue). Histological sectioning poses a challenge to obtaining perpendicular transversal cut to observing Kim-1 
at apical localization. See (C) to see an ideal perpendicular transversal section to observe apical expression of Kim-1.  
PT are outlined in white and RTECs with Kim-1 expression are marked with arrows. (D) Quantification of Kim-1 was 
acquired via area of Kim-1 expression in PT. Data pooled from 3 biological replicates are shown expressed as mean+/-
SEM. One-way ANOVA: *p<0.05, ****p<0.001, n.s.=not significant. Scale bar= 20 μm. 
2.2.3 Intact retinoic acid signaling pathway is required for PTBA efficacy 
In kidney development, RA concentration gradient is required to stimulate the formation 
of the proximal tubule specification in the zebrafish nephrogenesis 162 16. In mouse kidney 
development, renal stromal RA signaling is required for ureteric bud branching and nephrogenesis 
216 217 218. In rodent IR-AKI model, RA signaling pathway mediates macrophage polarization, 
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albeit the exact cellular mechanisms are not yet elucidated 157. Because RA signaling is a critical 
pathway in PT development, we hypothesized RA may be involved in the increased regeneration 
during injury. During zebrafish gent-AKI, RA signaling is reactivated within the first 7hpi and 
remains activated at 25hpi 157 To test whether RA pathway is required for UPHD25 efficacy, I 
treated gent-AKI Tg(PT:EGFP) fish with Ro41-5253 (Ro41), an RAR antagonist that effectively 
blocks RA signaling in zebrafish larvae 157. We analyzed proliferation by performing 
immunofluorescence microscopy and quantifying the number of PCNA-positive RTECs. In 
DMSO treated larvae, Ro41 did not significantly alter the number of PCNA-positive RTECs 
compared to untreated larvae (Figure 14A,B,E). UPHD25 treatment increased the number of 
PCNA-positive RTECs, while co-treatment with Ro41 and UPHD25 significantly decreased 
PCNA-positive RTECs compared to UPHD25 treatment alone (Figure 14C-E). Therefore, Ro41 
effectively blocks PTBA efficacy, suggesting that treatment requires intact RAR signaling to 
stimulate RTEC proliferation. 
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Figure 14 PTBA efficacy requires intact RA signaling 
Tg(PT:EGFP) transgenic zebrafish were used to analyze RTEC proliferation. (A-D) Immunofluorescence stain of 
RTECs actively undergoing S, G2, M-phase marked with PCNA antibody (red) and PT (green) in gent-AKI +DMSO 
(A), gent-AKI +Ro41 (B), gent-AKI +UPHD25 (C), and gent-AKI +Ro41 +UPHD25 (D). PT is outlined in white and 
arrows mark PCNA+ RTECs. (E) Quantification of PCNA+ RTECs in each treatment group. Data pooled from 3 
biological replicates are shown expressed as mean+/-SEM. One-way ANOVA: **p<0.01. Scale bar=20 μm. EE 
contributed to this figure. 
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To confirm the specificity of Ro41 experiments, we utilized an inducible transgenic 
zebrafish line Tg(hsp70l:EGFP-HS-dnRARα)ci1008 in which heat shock stimulates expression of a 
dominant-negative form of the human RA receptor alpha (DN-RARα) 219 220 221. We previously 
showed that UPHD25 treatment increased active RTEC proliferation in uninjured larvae 156. 
Therefore, we evaluated whether reducing RA signaling in this heat-inducible transgenic model 
would block UPHD25-stimulated RTEC proliferation. Uninjured Tg(hsp70l:EGFP-HS-dnRARα) 
larvae were heat shocked for 1hr at 5dpf then treated with either DMSO or UPHD25 for 24hrs. 
We quantified PCNA at 6dpf and compared proliferation to wildtype larvae treated with DMSO 
or UPHD25 (Figure 15A-E). Proliferation rates were comparable between heat-shocked (+HS) 
and non heat-shocked (-HS) larvae treated with DMSO (Figure 15A,B). However, UPHD25 -HS 
treatment showed impaired RTEC proliferation compared to UPHD25 +HS (Figure 15C,D). 
Therefore, in uninjured larvae, PTBA requires RA signaling to stimulate RTEC proliferation. 
Similarly, we evaluated proliferation in this transgenic model after AKI at 3dpf. At 2dpi, larvae 
were heat shocked for one hr and then treated with DMSO or UPHD25 for 24hrs (Figure 15F-J). 
Overall, gent-AKI larvae showed higher proliferation than the no injury group, suggesting injury 
results in increased proliferation. Within the Gent-AKI group, proliferation rates were comparable 
between DMSO +HS and DMSO -HS (Figure 15F,G). However, gent-AKI +UPHD25 +HS 
showed impaired RTEC proliferation compared to UPHD25 -HS controls (Figure 15H,I). Taken 
together, both pharmacologic or genetic inhibition of RAR signaling significantly reduces PTBA 
efficacy. The data indicate that the PTBA mechanism of action requires upstream RA signaling. 
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Figure 15 Dominant negative RARα expression reduces PTBA efficacy 
Uninjured (A-E) or gent-AKI (F-J) Tg(hsp70l:EGFP-HS-dnRARα) transgenic larvae were heat shocked at 5 dpf to 
express a dominant-negative form of human RA receptor alpha, which inhibits RA signaling. Larvae were treated with 
UPHD25 or DMSO then harvested for PT cell proliferation analysis (E, J). (A-H) Immunofluorescence staining for 
PCNA, marking proliferating cells in S-phase (red), 3G8, marking PT cells (green), and DAPI (blue) in uninjured fish 
treated with DMSO -HS (A) and +HS (B); uninjured fish treated with UPHD25 -HS(C) and +HS (D); gent-AKI fish 
treated with DMSO -HS (F) and +HS (G); and gent-AKI fish treated with UPHD25 -HS(H) and +HS (I). PT is outlined 
in white and arrows mark PCNA+ RTECs. (E) Quantification of PCNA+ RTECs in uninjured treatment groups. (J) 
Quantification of PCNA+ RTECs in gent-AKI treatment groups.. Data pooled from 3 biological replicates are shown 
expressed as mean+/-SEM. One-way ANOVA: *p<0.05, **p<0.01. Scale bar=20 μm. 
2.3 Methods 
2.3.1 Zebrafish husbandry 
Studies were approved by the University of Pittsburgh IACUC. Zebrafish were maintained 
as described 222In addition to AB wildtype, embryos were used from the following published 
transgenic lines: Tg(PT:EGFP)nz4 and Tg(cdh17:mCherry)pt307 156 157. Both males and females 
were used for the study. 
2.3.2 Gentamicin microinjection 
Zebrafish larvae were injected with a single dose of gentamicin at 3 dpf with 7.5ng of 
gentamicin as previously described
200
. Prior to the gentamicin injection, 3dpf zebrafish larvae were 
anesthetized in 0.2% tricaine/E3 medium (5mM NaCl, 0.33mM CaCl2, 0.33mM MgSO4, and 
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0.17mM KCl). Glass capillaries were pulled to produce microneedles and were aspirated with 10µl 
of 7.5ng/nl gentamicin solution diluted with filtered saline solution (Henry Schein, Cat No.: 
1049944). The larvae were injected with 1nl gentamicin solution, delivered via the common 
cardinal vein. After injection, larvae were incubated in 50μg/ml penicillin/streptomycin diluted in 
E3 medium. 
2.3.3 Compound treatment 
All compounds were diluted in E3 medium containing 0.5% DMSO. UPHD25 was 
synthesized by Enamine and used at a working concentration of 1μM. Larvae were treated with 
either DMSO or UPHD25 from 2-3dpi or 5-6dpf. For RA inhibition studies, zebrafish larvae were 
treated with 1 μM Ro41-5253 (Enzo Life Sciences) in 1% DMSO diluted in E3 for 24 hrs from 3 
to 4 dpf, and then were washed with several changes of E3.  
2.3.4 Heat shock treatment 
Tg(hsp701:GFP-dn_Hsa.rarα) transgenic fish were generated by gateway-based Tol2 
transposon transgenesis 223. Constructs were injected into single cell embryos and screened for 
insertion. Progeny of P0 founder animals were used to establish the zebrafish transgenic line. 
Animals were heat-shocked at 37°C for 1hr to induce the expression of human dominant negative 
RARα under the zebrafish hsp70l promoter. 
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2.3.5 Histological Analysis 
Immunofluorescence microscopy was performed on cryosections as described previously 
224. Larvae were fixed in 4% paraformaldehyde and treated with a 10-30% sucrose/PBS gradient 
before embedding in tissue freezing medium (Ted Pella). Sections were generated at a thickness 
of 12μm. Slides were blocked with 10% goat serum in PBST (0.1% Tween-20), followed by 
primary and secondary antibody incubations. Incubation with DAPI (Vector Laboratories) was 
used to counterstain nuclei. The slides were washed with PBS then mounted with Aqua Polymount 
(Polysciences). Sections were examined by confocal microscopy (Zeiss LSM 700).  
To quantify Pax2a-positive cells in Tg(PT:EGFP) fish, we imported serial images into ImageJ 
1.46r software (NIH). The ROI tool was used to outline the kidney in the green channel, and 
“Analyze Particle” function was used to quantify the number of Pax2a-positive cells in the red 
channel. Background and threshold values were constant between groups for each experiment. 
Particle size range was 80 to infinity. Per nephron, three images were analyzed. The protocol was 
used for PCNA immunofluorescence assays. Antibodies used are provided Table 1. 
2.3.6 RNA isolation of zebrafish pronephros 
6dpf Tg(PT:EGFP) larvae were used to collect GFP+ pronephros per treatment (N=70 for 
no injury ; N=100 for gent-AKI). The larvae were incubated in 10mM DTT in E3 and Tricaine for 
1.5-2 hrs at room temperature then with 5mg/ml Collagenase I in HBSS (Sigma Aldrich) for 2.5-
3.5 hrs at 32 ºC. The larvae were washed in Minimum Essential Media and 10% fetal calf serum 
(Gibco). Fine forceps and P10 pipette were used to dissect GPF+ pronephros. RNeasy Micro kit 
(Qiagen) was used for RNA isolation. 
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2.3.7 cDNA library preparation and RNA sequencing 
1μg of total RNA underwent mRNA library preparation using TruSeq Stranded mRNA kit 
(Illumina), according to manufacturer’s protocol. Final libraries were normalized to 10nM, pooled 
and diluted. NextSeq 500 were seeded with 1.8pM denatured library for automated cluster 
formation for approximately 30-40 million reads per sample. We used Hisat2 (v2.1.0) [PMID: 
25751142] to align paired-end RNA-seq reads to the zebrafish reference genome (UCSC 
danRer11) and gene-level counts per million (CPM) were calculated using featureCounts and 
edgeR 225,226. The RNA-seq data has been deposited in the Gene Expression Omnibus repository 
with the accession number GSE 126418. 
2.3.8 Statistical analysis 
Data were analyzed using student t-test, one-way ANOVA, and two-way ANOVA as 
indicated, and data are reported as mean ±SEM. P-values were considered significant when <0.05. 
When visible, both nephrons per fish were included. 
2.4 Discussion 
Upon AKI, RTECs undergo a repair process that starts with reactivation of developmental 
genes, such as Pax2, then increase proliferation to repopulate the tubular epithelium 98 38. Our work 
suggests that the PTBA enhances the endogenous repair process of the kidney.  In zebrafish, pax2a 
is required for PT development and specification. It is also activated during injury, suggesting the 
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innate reparative capacity of the zebrafish pronephric kidney 161 227 228. More interestingly, PTBA 
enhances Pax2a and PCNA-double positive RTEC numbers, suggesting PTBA enhanced RTEC 
cycling and proliferation. This reactivation of developmental genes usually accompanies EMT, in 
order for the cells to increase its proliferative capacity 228. We captured the activation of EMT 
using both immunohistology as well as RNA-sequencing. Both showed a window of upregulated 
mesenchymal genes as well as Vimentin and downregulation of epithelial genes, such as E-
cadherin. PTBA treatment enhances the population of RTECs that undergo EMT, accompanied by 
enhanced Pax2a expression, repair and re-differentiate into epithelial cells.  
We used Kim-1 as an injury biomarker to assess the effect of PTBA in RTEC health. Kim-
1 expression was lower in gent-AKI+UPHD25 than gent-AKI+DMSO at 3dpi, suggesting that 
PTBA attenuates injury. However, the mechanism of PTBA reducing Kim-1 should be carefully 
assessed: 1) PTBA may prevent RTECs from injury therefore precluding kim-1 expression during 
the treatment period; 2) PTBA may reverse RTECs injury, thereby turning off kim-1 expression 
during the process of Pax2 and EMT dedifferentiation. Earlier time course and cell-fate 
experiments can delineate the specific effect of PTBA on enhancing AKI recovery.  
Another pathway of interest was the RA signaling pathway, known to be critical for 
proximal tubule cell specification in the zebrafish pronephros and ureteric branching in the mouse 
kidney. It is shown to be significantly activated within hrs of AKI in the zebrafish RTECs 157. RA 
signaling in injury has a positive effect in repair, as inhibition of RA resulted in worsened survival 
and lower RTEC proliferation in gent-AKI zebrafish 157. We hypothesized this pathway will be 
enhanced with PTBA treatment. Previous results showed PTBA treatment enhances RA response 
elements 179. Our work showed that blocking of RA signaling pathway during PTBA treatment 
abrogated its proliferative effect. Our results suggest that RA activation is a necessary downstream 
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factor for PTBA mechanism of action. We conclude that PTBA prolongs the window of RA 
activation, having a positive repair effect by allowing longer window of redifferentiation and repair 
of the RTECs. The additional RA inhibition via a heat shock inducible model further strengthens 
our claim that abrogating the RA signaling pathway renders PTBA ineffective. Taken together, 
this work further characterizes the cellular mechanism of our novel compound PTBA as a 
promising candidate as an AKI therapeutic.  
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Ro41 data analysis was performed by Eugenel Espiritu 
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3.0 Characterizing innate immune system activation in larval zebrafish acute kidney injury 
3.1 Hypothesis 
One of the hallmarks of AKI is the early immune response, activated by the initial DAMP 
and PAMP released by RTECs and surrounding damaged tissue. Studies have reported that 
blocking neutrophil recruitment results in amelioration of AKI 141 229,230. Excessive macrophage 
recruitment and M1 activation lead to increased risk of further deterioration of kidney function 
and increased fibrosis 231. Previous study in mouse AA-AKI demonstrated that PTBA treatment 
decreases the total number of kidney macrophages and lowered inflammatory cytokines 177. Others 
have characterized the importance of macrophage polarization in diverging RTECs from 
undergoing repair or fibrosis 115. The larval zebrafish has a fully mature and functional innate 
immune system by 3dpf which is activated via well-conserved pathways, shown in context of fin 
clip injury model 170. Although the RTEC component of larval zebrafish AKI has been relatively 
well characterized, the immune system activation has not yet been investigated. I hypothesize that 
AKI resulting in cellular apoptosis and necrosis activates the innate immune system in the larval 
zebrafish model of AKI. PTBA treatment may have an indirect role in reducing leukocyte 
infiltration by enhancing RTEC repair and precluding DAMPs and leukocyte recruitment. 
Alternatively, PTBA may directly affect repair by directly changing macrophage polarization to 
more reparative M2 population.  
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3.2 Results 
3.2.1 Larval zebrafish AKI activates neutrophil migration 
PTBA treatment lowered RTEC expression of Kim-1, an AKI biomarker associated with 
prolonged inflammatory response and fibrosis in mice 39,45,215,232 (Figure 13). Thus, we determined 
whether PTBA affects the leukocyte response in the zebrafish gentamicin-AKI model. In 
mammals, AKI results in the rapid influx of neutrophils and macrophages, but these responses 
have not yet been characterized during AKI in zebrafish 233 234 235 115 236. Since the innate immune 
response is functional in zebrafish larvae by 3dpf, we first determined whether neutrophils and 
macrophages are activated and recruit to the site of injury in the PT 127. To evaluate the neutrophil 
response, we performed time-lapse confocal imaging in gent-AKI transgenic fish expressing 
mCherry driven by the cadherin-17 promoter, Tg(cdh17:mCherry), a renal tubule marker and 
enhanced GFP driven by the lysozyme C promoter, Tg(lyz:EGFP), a marker of neutrophils 237 238 
167 (Figure 16A). We captured z-stack images of the PT region over 17hrs beginning at 24 hpi. In 
uninjured fish, EGFP+ neutrophils migrate rapidly with few cells accumulating near the PT (Figure 
16B). In contrast, neutrophils in gent-AKI fish migrate slowly, and several migrated adjacent to 
the mCherry-positive kidney epithelium (Figure 16B). In order to quantify the response, we 
acquired samples at several time points and quantified EGFP+ neutrophils adjacent to the PT by 
examining serial sections (Figure 16C). At 4dpf (1dpi), there was no change in the number of renal 
neutrophils after gentamicin injection (Figure 16D). However, gent-AKI larvae showed more renal 
neutrophils at both 5dpf (2dpi) and 6dpf (3dpi), compared to uninjured controls (Figure 16D). 
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Figure 16 Neutrophil population changes in the kidney field during AKI 
Tg(cdh17:mCherry); Tg(lyz:EGFP) transgenic zebrafish were used for neutrophil analyses. (A) Uninjured (left) and 
gent-AKI (right)  at 3dpf and imaged at 2dpi (B) Snapshots of live imaging of lyz :GFP+ neutrophils imaged at 1 dpi 
for 13.5 hrs. Imaged fish were age matched uninjured (left) and gent-AKI (right)  (C) Immunofluorescence co-stain 
of PT (red or green) and neutrophils (green) in no-injury and gent-AKI at 3 dpi. PT is outlined in white and adjacent 
leukocytes are marked with arrows. (D) Quantification of neutrophil adjacent to PT before and after injury. Adjacent 
leukocytes were counted for both no injury and gent-AKI at 1, 2, 3 dpi. Data pooled from 3 biological replicates are 
shown expressed as mean+/-SEM. One-way ANOVA: *p<0.05, **p<0.01, ***p<0.005. Scale bar=20 μm. 
3.2.2 Larval zebrafish AKI activates macrophage migration 
We also performed imaging and histological studies to evaluate the macrophage response. 
To visually detect macrophages, we utilized the transgenic reporter line, Tg(mpeg1:dendra2) in 
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which macrophages are green 239. We performed live time-lapse imaging in Tg(cdh17:mCherry); 
Tg(mpeg1:dendra2) double transgenic fish after gentamicin injection (Figure 17A). Unlike the 
neutrophils, the macrophages did not increase in recruitment at the early timepoint of 24hpi. 
Therefore, we captured z-stack images of the PT and macrophage recruitment at a later timepoint, 
starting at 48hpi, over 20hrs (Figure 17B). Uninjured fish display mpeg:dendra2+ macrophages 
circulating rapidly; however, only a few macrophages made prolonged contact with the PT (Figure 
17B). In contrast, gent-AKI fish showed recruitment and retention of many macrophages to the 
mCherry+ kidney epithelium (Figure 17B). To quantify this response, we fixed 
Tg(mpeg1:dendra2); Tg(cdh17:mcherry) double transgenic fish and quantified the number of 
Dendra2+ macrophages adjacent to the PT (Figure 17D). Compared to uninjured fish, gent-AKI 
larvae showed an increased number of renal macrophages at 3 dpi (Figure 17C,D). Taken together, 
these data indicate that the gent-AKI zebrafish larvae show a robust innate immune response 
between 2-3 dpi.  
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Figure 17 Macrophage population changes in the kidney field after AKI 
Tg(cdh17:mCherry); Tg(mpeg1;dendra2) transgenic zebrafish were used for macrophage analyses. (A) Uninjured 
(left) and gent-AKI (right) at 3 dpf and imaged at 2 dpi . (B) Snapshots of live imaging of mpeg1+ macrophages 
imaged at 2 dpi for 19.5 hrs in no injury and gent-AKI setting. (C) Immunofluorescence co-stain of PT (green) and 
macrophages (red) in no-injury and gent-AKI at 3 dpi. PT is outlined in white and adjacent leukocytes are marked 
with arrows. (D) Quantification of macrophage numbers adjacent to PT before and after injury. Data pooled from 3 
biological replicates are shown expressed as mean+/-SEM. One-way ANOVA: *p<0.05, **p<0.01, ***p<0.005. Scale 
bar=20 μm. 
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3.2.3 PTBA treatment decreases macrophage migration 
We have characterized the neutrophil response, which begins within the first 24hrs after 
injury and remains until 3dpi (Figure 16). Macrophages, however, respond at later time points, 
starting after 24hpi and reaching their peak at 3dpi (Figure 17). Having characterized the timing 
of neutrophil and macrophage influx during gent-AKI in zebrafish larvae, we assessed whether 
PTBA affects the leukocytic immune response. We treated gent-AKI Tg(lyz:EGFP) or 
Tg(mpeg1:dendra2) with DMSO or UPHD25, and quantified renal neutrophils and macrophages 
at 3 dpi (Figure 18A,B). At this time point, there was no change in the number of neutrophils, but 
there was a small but significant decrease in the number of macrophages between treatment groups. 
This suggests that PTBA does not affect initial neutrophil recruitment but may decrease the overall 
number of macrophages that are recruited to the PT (Figure 18C,D).  
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Figure 18 PTBA treatment lowers total macrophage recdruitment during early AKI 
(A) Tg(cdh17:mCherry); Tg(lyz:EGFP) transgenic zebrafish were used for neutrophil analyses 
(B)Tg(cdh17:mCherry); Tg(mpeg1;dendra2) transgenic zebrafish were used for macrophage analyses. Images of 
peritubular macrophages after DMSO (left) or UPHD25 (right) treatment Images of peritubular neutrophils or 
macrophages after DMSO (left) or UPHD25 (right) treatment. Fish were injecdted at 3dpf and treated from 2-3dpi 
then imaged at 3dpi. PT is outlined in white and adjacent leukocytes are marked with arrows. (C) Quantification of 
lyz+ neutrophils. (D) Quantification of mpeg1+ macrophages. Data pooled from 3 biological replicates are shown 
expressed as mean+/-SEM. two-tailed t-test: *p<0.05, ns=not significant. Scale bar=20 μm. 
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3.2.4 PTBA treatment affects macrophage polarization 
We then wanted to determine whether PTBA affected macrophage polarization 235 115 236. 
Studies have shown that zebrafish undergo M1/M2 polarization akin to their mammalian 
counterparts 170 240. Since the mpeg1 transgenic line is a reporter for all macrophage phenotypes, 
we stained the Tg(mpeg1:dendra2) fish with anti-TNF antibody, an M1-specific pro-
inflammatory cytokine 170. To quantify M2 macrophages, we utilized a similar staining method, 
but used an M2 specific marker, anti-Arginase-2 antibody 240. To validate the specificity of the 
Arginase-2 antibody, in situ hybridization pattern was once again compared to the protein 
expression (Figure 19). Since other pro-inflammatory cells also express TNF, we quantified the 
ratio of cells that co-labelled TNF+/mpeg1:dendra2+. In gent-AKI+DMSO treated fish, many M1 
macrophages are recruited to RTECs, while gent-AKI+UPHD25 treated fish display fewer M1 
macrophages (Figure 20A-C). Comparing gent-AKI+DMSO with gent-AKI+UPHD25 treated 
fish, we found no change in the number of M2 macrophages in the renal field (Figure 20D-F). 
Overall, these results suggest that PTBA reduces total macrophage recruitment and the number of 
inflammatory macrophages to the damaged tubule.  
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Figure 19 Validation of Arginase-2 antibody via in situ hybridization 
To validate the M2 marker Arginase-2, in situ hybridization was used to localize mRNA and compared the 
expression pattern to immunofluorescence staining with anti-Arginase-2 antibody. (A) In situ hybridization of 
arginase-2 on frozen section of 6 dpf uninjured larvae demonstrates positive staining in the somites (outlined in red) 
and pectoral fin (red arrow), consistent with previously reported spatiotemporal expression (Thisse 2004 ZFIN 
publication). (B) Immunofluorescence staining in uninjured larvae at 6 dpf with anti-Arginase-2 antibody (Thermo 
Fisher Scientific PA5-27987, 1:100) demonstrates congruent staining pattern, with positive staining in somites 
(outlined in red) and pectoral fin (red arrow). Scale bar= 20μm. 
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Figure 20 PTBA treatment reduces total M1 macrophage population, 
Tg(mpeg1:dendra2); Tg(PT:EGFP) transgenic zebrafish were used for macrophage polarization analysis. (A, B) 
Immunofluorescence co-stain of TNFα (red), macrophages (blue), and PT (green) in gent-AKI +DMSO (A) and gent-
AKI +UPHD25 (B). PT is outlined in white. TNFα+/mpeg1+ are marked with an asterisk and TNFα-/mpeg1 are marked 
with an arrow. (C) Quantification of M1 macrophage recruitment by counting TNFα+/mpeg1+ cells adjacent to PT. 
(D, E) Immunofluorescence co-stain of arginase-2 (red), macrophages (blue), and PT (green) in gent-AKI +DMSO 
(D) and gent-AKI +UPHD25 (E). Arg2+/mpeg1+ are marked with an asterisk and Arg-2-/mpeg1+ cells are marked with 
an arrow. (F) Quantification of M2 macrophage recruitment by counting Arg-2+/mpeg1+ cells adjacent to PT. 
Macrophage numbers were normalized by calculating ratio of M1 or M2 over total macrophages; i.e. 
(TNFα+/mpeg1+)/total mpeg1+. Data pooled from 3 biological replicates are shown expressed as mean+/-SEM. 2-
tailed t-test: **p<0.01, n.s.= not significant. Scale bar=20 μM. 
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3.3 Methods 
3.3.1 Zebrafish husbandry 
Zebrafish husbandry was conducted as stated in Chapter 2 
3.3.2 Gentamicin microinjection 
Gentamicin microinjection was conducted as stated in Chapter 2 
3.3.3 Compound treatment 
Compound treatment was conducted as stated in Chapter 2 
3.3.4 Live two-photon confocal imaging 
24hrs after gentamicin injection, Tg(cdh17:mCherry);Tg(lyz:EGFP) larvae were 
anesthetized in tricaine, embedded in a thin layer of 0.5% low-melt Sea Plaque agarose (Cambrex), 
and covered with E3 medium / 0.003% PTU to prevent pigment development. Image stacks were 
acquired using a Leica TCS SP5 multiphoton microscope (Leica Microsystems) with an HCX 
IRAPO L 20X/0.95 water immersion objective, non-descanned detectors and a custom-built 
motorized stage (Scientifica). Sequential stack scanning was performed bidirectionally with a 
resonant scanner (16000 Hz, phase set to 1.69) with 32x line averaging and a zoom of 1.7x. EGFP 
and mCherry were excited with a Mai Tai DeepSee Ti:Sapphire laser (Newport/Spectra Physics) 
at 900 and 561 nm, respectively. Using the “Mark and Find” function, (x,y) coordinates and z-
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series parameters (step size 1.48μm) were defined for individual larvae. Images were captured 
every 27 mins for 17hrs. Maximal projections were compiled in series to generate time-lapse 
movies using LAS AF Version: 3.0.0 build 8134 and Metamorph software.  
48hrs after gentamicin injection, Tg(cdh17:mCherry);Tg(mpeg1:dendra2) larvae were processed 
for imaging using the protocol above. Image stacks were acquired using Nikon Eclipse Ti confocal 
microscope (Nikon Instruments) with a 20X dry objective, and a motorized stage. Stacks were 
captured with 40 optical sections, with 5μm step size. Dendra2 and mCherry were excited with 
488nm and 560nm lasers, respectively. Dendra2 is photoconvertible with 488nm and UV but 
maintains its original green fluorescence emission (509nm) when imaged under laser power 
between 2-7%. Experiments utilizing Tg(mpeg1:dendra2) maintained low laser power to inhibit 
photoconversion from green to red. Using the “Mark and Find” function, (x,y) coordinates and z-
series parameters (5μm ) were defined for individual larvae. Images were captured every 90 mins 
for 24hrs. Maximal projections were compiled in series to generate time-lapse movies using Imaris 
image analysis software (Bitplane).  
3.3.5 Histological analysis 
Histological analysis was conducted as stated in Chapter 2. Antibodies used are provided 
Table 1. As with Chapter 2, similar ImageJ analysis was performed in Tg(PT:EGFP); 
Tg(mpeg1:dendra2) fish to quantify macrophage cell size. For these images, there was no 
background removal, mpeg1:dendra2 channel threshold was 53 to 255, and particle size range was 
60 to infinity. 
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3.3.6 In situ hybridization 
The arginase-2 clone was synthesized and cloned into pEX-K248 with Sp6 promoter to 
drive the reverse transcription (Eurofins). The arg-2 clone was synthesized and cloned into pEX-
K248 with Sp6 promoter to drive the reverse transcription (Eurofins). The digoxigenin (DIG) 
probe for arg-2 targeted 500bp of 3’ end of coding region and 500bp of 3’UTR. 6dpf larvae were 
fixed in 4% PFA/PBS overnight at 4°C. Larvae were washed in PBS. Larvae were dehydrated in 
of MeOH and then moved to -20°C for 1hr. Larvae were transferred to acetone for 10min at -20°C. 
Larvae were rehydrated in PBS and treated with 100g/ml Proteinase-K in 
PBS/0.2%BSA/0.1%Tween-20 (PBTw) for 30min at RT. Larvae were again fixed in 4% PFA for 
20min. Larvae were incubated with the arg-2 probe overnight at 65°C. Larvae were incubated in 
1:2000 anti-DIG Alkaline Phosphatase antibody (Roche) overnight at 4°C. The larvae were stained 
with BM purple (Roche) RT. The reaction was stopped with 4% PFA. Larvae were then 
cryosectioned at 25μm and imaged using a 20X objective on an Axiovert 40 CFL brightfield scope 
(Zeiss). Images were captured using Axiovision Rel v4.8 software (Zeiss). 
3.4 Discussion 
While the zebrafish leukocyte system has been relatively well studied, its activation in the 
context of zebrafish AKI had not been elucidated 103,137,170,241. Here, we demonstrated leukocyte 
activation in real-time during AKI, which has never been described in literature. In addition, we 
applied our knowledge of leukocyte activity to further characterize PTBA’s role in modulating this 
immune environment. 
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Results of the neutrophil assays suggest that the larval zebrafish AKI model is comparable 
to mammalian AKI models, in that neutrophils serve as the first line of defense. Neutrophils are 
seen in the live imaging as early as 24hpi, reaching the peak of infiltration at 2 and 3dpi. No change 
in neutrophil numbers are observed when treated with PTBA. Given that neutrophils are the first 
responders within the first day of injury, it is expected that the later PTBA treatment window 
should not affect its infiltration. The assay of neutrophil population at 3dpi suggests that neutrophil 
dissolution is not affected by the compound treatment. Results show that while neutrophils are 
activated by AKI, PTBA has no effect on driving their infiltration or their resolution.  
Results of initial macrophage recruitment assays suggest that the larval zebrafish AKI 
model is comparable to mammalian AKI models. As seen in mammalian AKI models, macrophage 
infiltration occurs following the neutrophil activation, presumably due to neutrophils conferring 
macrophages via chemokines and cytokines, such as G-CSF, GM-CSF, INF-, IL-8, MIP-1, Type 
I IFNs, and Type II INF 242. The real time imaging reveals a larger population of macrophages that 
are recruited to cdh17+ PT that are undergoing phagocytosis from 2-3dpi. PTBA treatment slightly 
decreases tubular macrophage infiltration when observed at 3dpi. This could be attributed to lower 
initial infiltration due to a healthier environment, less expression of DAMPs, thus fewer recruited 
macrophage. Alternatively, PTBA may play a direct role in macrophage recruitment. Time course 
experiments to measure RTEC-specific cytokines and chemokines may lend insight into whether 
the damage associated cytokines are resolved prior to recruiting macrophages.  
Interestingly, macrophage polarization was altered with UPHD25 treatment. We saw a 
significant decrease in TNF+/mpeg1:dendra2+ or M1 macrophages in gent-AKI UPHD25 fish. 
However, we did not see a significant increase in Arg2+/mpeg1:dendra2+ or M2 macrophages. The 
lack of M1 macrophages may be an indirect consequence of healthier, repaired RTECs expressing 
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lower inflammatory cytokines and chemokines. Conversely, PTBA may have a direct, cell-
autonomous impact on polarization through modulating the RA signaling pathway. Chiba et al. 
have shown a paracrine and autocrine RA signaling interplay between two cell types: macrophages 
and RTECs 210. Macrophage-derived production of RA to lower M1 population in the interstitium 
of the kidney. In RTECs, intact RAR expression is required to convert M1 to M2 in the interstitium 
to increase M2 macrophages. Furthermore, it has been shown that RA treatment inhibits the 
production of inflammatory cytokines and also increases of tolerance to cytokines 243. Retinoid 
treatment inhibits production of IL-12 in LPS-activated macrophages by competitive inhibition of 
RXR and NF-kB process 244. Vitamin A deficient mice fail to convert tissue resident macrophages 
during infection, leading to deregulated inflammatory response 245. RA is anti-inflammatory effect 
as exogenous RA administration in diabetic nephropathy and ulcerative colitis resulted in 
decreased inflammatory marker via suppressing TLR-4 activation and NF-kB nuclear localization 
246 247. Taken together, the modulation of RA pathway via PTBA may have a direct impact on 
macrophage transcriptional activity of inflammatory cytokine production. Taken together, this 
study demonstrates the very conserved nature of the leukocytic response between the larval 
zebrafish and mammalian AKI models. Taking advantage of the conserved nature of innate 
immune response, we have characterized the interaction between PTBA and the immune system. 
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Lauren Skvarca contributed to initial neutrophil and macrophage recruitment experiment 
 
Material modified and re-published with permission 
Brilli Skvarca L, Han HI, Espiritu EB, et al. Enhancing regeneration after acute kidney injury by promoting cellular 
dedifferentiation in zebrafish. Dis Model Mech. 2019;12(4):dmm037390. Published 2019 Apr 5. 
doi:10.1242/dmm.037390 
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4.0 hdac8 knockout results in enhanced repair after acute kidney injury  
4.1 Hypothesis 
Various HDACs are expressed in the kidney and they play a complex role in development 
and disease progression 178. Studies have reported confounding results due to the complexity of 
cellular interactions that occur during an AKI event 248 185. One of the challenges of HDAC 
inhibition studies is the nature of selectivity. Treatment with pan-HDIs results in inhibition of 
multiple HDACs whereas selective-HDIs inhibit one or two specific HDACs 249. The broad 
inhibitory effect of most HDI is not ideal, since individual HDAC have diverse functions under 
physiologically different scenarios 249. Previously, we published that PTBA, an HDI, enhances 
regenerative capacity in various models of AKI 155 177 176. However, its direct binding target and 
downstream pathways have yet to be elucidated, both required knowledge to translate PTBA into 
a human therapeutic. In this chapter we first utilized in vitro and in vivo selectivity assays to 
identify HDAC8 as the target of PTBA. Then, we utilized hdac8 mutant zebrafish to assess its 
roles in post-AKI repair using various assays to measure overall survival, RTEC cell cycle 
dynamics, transcript analysis, and bulk RNA-sequencing. I hypothesized that hdac8 knockout 
zebrafish will result in enhanced repair after AKI, by affecting the acetylation state of HDAC8’s 
downstream target that may be important for RTEC cell cycle progression. 
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4.2 Results 
4.2.1 PTBA selectively binds to HDAC8 
Based on its classic cap, linker, warhead structure, our pro-regenerative compound PTBA 
was identified as a class I HDI 158 178 148. HDAC specificity is important to minimize unwanted 
binding and potential side effects. Therefore, we used cellular thermostability assay (CETSA), to 
assess PTBA binding to class I and class II HDAC members (Figure 21). While traditional 
thermostability assays uses a single protein of interest grown and isolated in culture, CETSA uses 
the cellular contents 250. Because HDACs can be found in large complexes, with multiple co-
factors and other proteins, we used CETSA to determine the binding specificity of PTBA to 
different HDACs 251. CETSA uses the inherent thermodynamic properties of a protein’s structure 
to determine the amount of kinetic energy required to melt the protein 252. Each protein has a 
specific melt temperature (Tm), the temperature at which half of the protein is in the folded soluble 
form and the other half insoluble aggregate 253. When a protein (HDAC) binds to a selective ligand 
(PTBA), additional energy is necessary to overcome the biophysical interactions within the 
protein/ligand for the protein to unfold. This results in an increase in the Tm of the HDAC/PTBA 
complexes compared to the unbound HDAC 254. HEK293T cells were transfected with plasmids 
of specific HDACs containing an N-terminus HALO tag, then the cell lysates were incubated with 
10M PTBA, or DMSO. The samples were subjected to the thermostability gradient, visualized 
by Western blot, and fitted to the Boltzman constant sigmoidal curve to calculate the Tm. HDAC8 
and PTBA increased the Tm compared to DMSO control by 3.43°C 255 (Figure 21A). Modification 
to the CETSA experiment known as isothermal dose response curves (ITDR) uses the known Tm 
for the protein and a concentration gradient of compound to calculate the IC50 256. Results showed 
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an IC50 of 17nM for HDAC8 (Figure 21B). Other class I HDACs did not show increased stability 
with PTBA (Figure 21C).  
To validate that our CETSA experiment demonstrated that PTBA was binding to HDAC8, 
we performed CETSA on a known HDAC8 selective inhibitor, PCI-34051257. PCI-34051 
increased the Tm by 3.46°C (Figure 21D). Further validation with ITDR for HDAC8 identified the 
IC50 of 8.4nM (Figure 21E). Taken together, the in vitro data suggests PTBA selectively binds to 
HDAC8 over other class 1 and class2 HDACs.   
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Figure 21 PTBA selectively binds to HDAC8 
(A) CETSA curves of HEK297T cell lysates transfected with HDAC8-HALO tag. The lysates were incubated with 
10M PTBA or 0.1% DMSO. TmDMSO=49.25C. TmPTBA=58.11C. (B) ITDR curves of HDAC8 using log-fold 
concentration gradient of PTBA, incubated at 58.11C. (C) ITDR of class I and class II HDACs were calculated using 
the method presented in (B). Only HDAC8 had a detectable IC50 of 17.13nM. (D) CETSA curves of HEK297T cell 
lysates transfected with HDAC8-HALO tag. The lysates were incubated with 20M PCI-34051 or 0.1% DMSO. 
TmDMSO=45.32C. TmPCI-34051=64.70C. 3 biological replicates were performed. (E) ITDR curves of HDAC8 
using log-fold concentration gradient of PCI, incubated at 49.60C.  
4.2.2 hdac8 loss of function mutants show enhanced survival after AKI 
To confirm the selectivity of PTBA against HDAC8, we used a hdac8 mutant zebrafish 
line, hdac8sa14948, a T → A point-mutation resulting in an early stop codon at exon 5Figure 22A) 
258. Further amino acid alignment of the mutant allele predicted a truncation of the translated 
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product from 378aa to 154aa (Figure 22B). Both heterozygous (hdac8-/+) and homozygous (hdac8-
/-) larvae were embryonically viable and reached maturity. This viability in loss-of-function 
organism is also observed in humans and mice. For example, adult human patients with Cornelia 
de Lange Syndrome (CdLS), a developmental defect due to mutations in hdac8 showed 
undetectable levels of HDAC8 187. In mice, HDAC8 loss of function mutants showed sub-
Mendelian levels of viability, and displayed a failure to thrive and usually died with 4-6hrs after 
birth 182. Upon postmortem analysis, HDAC8-/- mice revealed no visible defects in the kidney, 
liver, heart, lung, intestine, and bladder but showed brain and skull development defects 182. In our 
zebrafish larvae model, we performed transcript analyses of hdac8-/- fish using both qPCR and in 
situ hybridization at multiple timepoints, showing a distinct absence of hdac8 mRNA, suggesting 
that the mutants undergo nonsense mediated decay and result in no translated protein (Figure 
22C,D).   
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Figure 22 Characterization of hdac8sa14948 larval zebrafish 
Sanger sequencing chromatogram of hdac8sa14948 site of lesion. Wildtype (WT), heterozygous hdac8sa14948/+, and 
homozygous hdac8sa14948/-. Nonsense mutation from T to A (peaks highlighted in blue) resulting in an early stop 
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codon at exon 5 (B) Amino acid alignment of WT HDAC8 (378aa) and predicted hdac8sa14948 HDAC8 (154aa) using 
Needleman-Wunsch method. • represents identical aa, - represents different aa, * represents stop codon. (C) Whole 
mount zebrafish in situ hybridization to visualize hdac8 transcripts localization. Both WT and hdac8-/- were analyzed 
at various timepoints from 8hpf,1-6dpf. (D) RT-PCR of hdac8 transcript quantification of WT and hdac8-/-  2mo old 
adult fin clips. Student’s t-test was used. 
 
To examine whether homozygous fish were embryonically viable, hdac8-/+ were in-
crossed, and the resulting clutch of embryos were reared until adulthood then genotyped. The 
clutch showed the expected Mendelian pattern (Figure 23A). We observed a low penetrance of 
craniofacial deformity of 1% in all homozygous adults similar to craniofacial deformities observed 
both in mice and humans lacking HDAC8 188,190 182 (Figure 23B,C). 
 
 
Figure 23 Characterization of hdac8sa14948 adult zebrafish 
(A) Expected and observed Mendelian ratio of heterozygous in-cross to examine hdac8 mutation survivability. (B) 
Analysis of craniofacial deformity (CFD) frequency. Frequency of CFD was counted in 3 independent clutches. 1% 
of homozygous mutants displayed craniofacial deformity (C) Images depict normal (top) and CFD (bottom) 
phenotypes. 3 independent clutches were reared to adulthood, with total of N=102 adult fish examined. 
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Since we demonstrated that PTBA is a selective HDAC8 inhibitor, and the hdac8-/- were 
viable, we compared the survival response in WT, hdac8-/+, and hdac8-/- larvae in our nephrotoxin 
AKI model 156 (Figure 24A). A cohort of wildtype and heterozygous and homozygous mutants 
were injected with gentamicin to induce gent-AKI and then observed for the rate of survival until 
7dpi. hdac8-/- fish showed significantly enhanced survival compared to WT and hdac8-/+ fish 
(Figure 24G). This data suggests the loss of HDAC8 function enhanced survival in our nephrotoxin 
larval zebrafish model. 
 
 
Figure 24 hdac8 loss of function results in enhanced post-AKI survival 
(A) Survival curves of gent-AKI zebrafish of WT, hdac8-/+, and hdac8-/-. A cohort of larvae were given gent-AKI then 
recorded from 1-7dpi for survival. Log-rank (Mantel-Cox) test was used compare survival to the control (white circle). 
3 biological replicates were conducted. ****p<0.0001. n.s.=not significant. 
4.2.3 hdac8 is required for PTBA efficacy 
Having shown PTBA selectivity to HDAC8 in vitro, we aimed to show PTBA selectivity 
to HDAC8 in vivo. To confirm in vivo selectivity of PTBA, we assessed efficacy of the compound 
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with suboptimal or lack of hdac8 expression. If PTBA selectively binds to and inhibits HDAC8 to 
enhance repair, then PTBA treatment in the absence of HDAC8 should result in a loss of PTBA 
efficacy. Zebrafish larvae treated with PTBA analog UPHD25 showed a significantly increased 
survival when compared to vehicle treated larvae (Figure 25A). As a known selective inhibitor of 
HDAC8, PCI-34051, was also used to test if pharmacological inhibition of HDAC8 would result 
in enhanced post-AKI survival. Gent-AKI fish treated with PCI-34051 showed an improved 
survival when compared to the vehicle treatment (Figure 25B). We then wanted to test the 
requirement of HDAC8 in PTBA efficacy. If HDAC8 inhibition is required for PTBA’s efficacy, 
then absence of HDAC8 should render the compound ineffective, since there is no functional 
protein to inactivate. We first determined a suboptimal dose of UPHD25 by performing survival 
assays of various concentrations. Compound efficacy on survival was concentration dependent, 
with the highest dose (4M) resulting in the highest survival (Figure 25C). At 1M PTBA, survival 
was not significantly affected but has been previously shown to enhance cellular response to AKI 
(Figure 25C). Therefore, 1M was determined as a suboptimal concentration, the lowest dosage 
still beneficial with minimum possibility of nonselective binding to other targets. We treated WT, 
hdac8-/+, and hdac8-/- with 1M UPHD25 to test if HDAC8 is required for PTBA efficacy. WT 
expressing functioning HDAC8 showed increased survival as expected (Figure 25D). hdac8-/+also 
benefited from the suboptimal dose of the compound, suggesting one intact copy of hdac8 is 
sufficient for PTBA to bind, inhibit, and impart benefits to post-AKI recovery (Figure 25D). 
However, hdac8-/- fish showed significantly lower survival compared to the siblings (Figure 25D). 
While unexpected, the lower survival in hdac8-/- may stem from non-specific binding of PTBA to 
other proteins in the absence of HDAC8, rendering the PTBA treated-hdac8-/-more vulnerable to 
injury response.  
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Figure 25 HDAC8 expression is required for PTBA efficacy 
(A) WT fish survival curves of UPHD25 and vehicle (0.5%DMSO). (B) WT fish survival curves of known HDAC8 
inhibitor, PCI-34051, and vehicle (0.5%DMSO) (C) WT fish survival curves of UPHD25 concentration gradient of 
0.5M, 1M, 2M, 4M and vehicle (0.5%DMSO) to identify the suboptimal dose. A cohort of larvae were given 
gent-AKI then recorded from 1-7dpi for survival. Log-rank (Mantel-Cox) test was used compare survival to the 
controls (white circle). 3 biological replicates were conducted.*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
n.s.=not significant. (D) Survival curves of WT, hdac8-/+, and hdac8-/-. treated with suboptimal dose of UPHD25 
(1M) and vehicle (0.5%DMSO) 1 biological replicate was conducted. 
4.2.4 hdac8 loss of function results in cell cycle delay 
Next, we examined cellular hallmarks of injury in hdac8-/-. Classic hallmarks of AKI are 
increased RTEC cell cycling, cell cycle arrest, and proliferation, which must occur in fine balance 
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to achieve adaptive repair 199 75 65 95. In larval zebrafish model of AKI, RTECs show an increase 
in proliferation in the days following an AKI event 156 158. We assessed whether there is a change 
in the cell cycle dynamics, as HDAC8 deacetylates cell-cycle related factors, such as SMC3 186 201 
259 260 185. We treated fish with 5-Ethynyl-2’-deoxyuridine (EdU), a thymidine analog, for 24hrs 
prior to harvesting, to capture the population of RTECs cells undergoing S-phase at 3 and 4dpi. At 
3dpi, hdac8-/-AKI had a higher population of S-phase RTECs than WT AKI (Figure 26A,B). At 
4dpi, hdac8-/- AKI again showed a higher population of S-phase RTECs than in WT AKI (Figure 
26A,B). To assess whether other cell cycle phases follow a similar trend, we stained with phospho-
Histone3 (pH3), a marker of cells undergoing G2/M 261 262 263. At 3dpi, hdac8-/- AKI showed no 
change in pH3 expression than WT AKI, an opposite trend than the increase in S-phase RTECs in 
hdac8-/- AKI (Figure 26C,D). At 4dpi, hdac8-/-AKI showed a higher number of pH3+ than WT 
AKI (Figure 26C,D). At 3dpi, hdac8-/- RTECs show an increase in S-phase cell numbers but no 
change in G2/M. At 4dpi, hdac8-/- RTECs show an increase in S-phase cell numbers as well as 
well as an increase in G2/M cell numbers. Data suggests that hdac8-/- fish show a delay of cell 
cycle at 3dpi but allows cell cycle recovery and subsequent cell division at 4dpi.  
To validate this claim, we harvested early to late (1-4dpi) RTECs and searched for 
indications of cellular delay and recovery. We used qPCR to quantify the expression cellular arrest 
marker, cdkn1a or p21a, a checkpoint inhibitor 264 265 266 (Figure 26E). During DNA damage, an 
upstream DDR response will cascade into increased expression of p21 to arrest cells at either G1/S 
or G2/M 78(Figure 5, Figure 6). After injury is resolved at G1/S, p21 expression declines to recover 
cell cycle progression whereas injury at G2/M is likely to result in irreversible arrest and mitotic 
catastrophe 78 267(Figure 5, Figure 6). In our model, WT and hdac8-/- fish have differential 
expression of p21a. In hdac8-/-AKI, p21a expression increases steadily from 1dpi to 3dpi then 
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decreases at 4dpi (Figure 26E). This correlates with the EdU and pH3 immunofluorescence data, 
which suggests slowing of division at 3dpi followed by recovery of cell cycling and increased 
RTEC division at 4dpi (Figure 26A-D). Conversely, in WT AKI p21a level continues to increase 
from 1dpi to 4dpi, which indicates irreversible cell cycle arrest and thus decline of RTEC health 
20 199 75 (Figure 26E). Data suggests that hdac8-/- contributes to cell cycle delay up to 3dpi then 
recovery at 4dpi to increase in RTEC proliferation. 
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Figure 26 hdac8 loss of function results in changes in cell cycle dynamics 
(A) Immunofluorescence of EdU pulse chase to quantify S-phase cells. EdU was treated for 24h before harvesting. 
PT of WT AKI 3dpi, WT AKI 4dpi, hdac8-/- AKI 3dpi, hdac8-/- AKI 4dpi are captured. EdU (magenta) marks S-
phase cells, GFP (green) marks PT, DAPI (grey) marks nuclei. PT are outlined in white. Scale bar= 20m. (B) 
Quantification of EdU cells in PT. 3 biological replicates were conducted. 3 biological replicates were conducted. 
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One-way ANOVA was used for statistical analysis. Results represented as Mean +/- SEM. **p<0.01 
(C)Immunofluorescence of pH3 to quantify G2/M-phase cells. PT of WT AKI 3dpi, WT AKI 4dpi, hdac8-/- AKI 
3dpi, hdac8-/- AKI 4dpi are captured. pH3 (red) marks G2/M cells, GFP (green) marks PT, DAPI (grey) marks 
nuclei. PT are outlined in white. Scale bar= 20m. (D) Quantification of pH3 cells in PT. One-way ANOVA was 
used for statistical analysis. 3 biological replicates were conducted. Results represented as Mean +/- SEM. *p<0.01 
n.s.=not significant. (E) RT-PCR of p21a transcripts from PT cells collected from 1dpi (4dpi) to 4dpi (7dpf). White 
dots represent WT AKI. Black dots represent hdac8-/- AKI. RQ represents relative quantification. 
 
To identify mechanism underlying this cell cycle change, we looked at an HDAC8 target 
that plays a role in cell cycle dynamics. Structural maintenance of chromosome 3a (SMC3a) is a 
well characterized target that acts as an essential subunit in the cohesin ring required for cell 
cycling, chromosome stability, DNA repair, and transcription regulation 268 188 269 260 (Figure 9). 
The cohesin ring is loaded onto 2N chromosome at G1200 270. During the replicative S phase, the 
resulting sister chromatids stay together via the “locked” cohesin ring 200 270. The “locked” 
conformation change is possible when N-acetyltransferase Establishment of cohesion 1 homolog 
2 (ESCO2) acetylates SMC3, thereby stabilizing the sister chromatin 200 270. During the G2 phase, 
sister chromatids are maintained until mitosis when the two daughter cells undergo anaphase 200 
270. In order to free sister chromatids, the enzyme Separase dissolves the cohesin ring and frees the 
individual components, including the previously acetylated SMC3Ac 200 270. In the ensuing cell 
cycle, the SMC3Ac must be deacetylated to allow it to bind to the 2N chromosome at G1200 270. It 
will not be loaded onto the 2N chromosome unless it is in the deacetylated conformation 200 270 202 
201 187. HDAC8 deacetylates and changes the acetylation state from SMC3Ac to SMC3 202 201 187. 
Without functional HDAC8, there is a higher ratio of SMC3aAc /SMC3 186. This higher 
concentration of SMC3aAc delays the efficient loading of unacetylated SMC3 onto the chromatin, 
thereby resulting in inefficient cell cycling and delay 184 186. We hypothesized that the cell cycle 
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delay in hdac8-/- may be attributed to an abundance of SMC3Ac. To test this hypothesis, we 
quantified the Smc3aAc using western blot. Results showed a 2-fold increase SMC3aAc /SMC3 
ratio in hdac8-/- fish compared to WT fish (Figure 27A,B) 
To test our hypothesis that a cell cycle delay at 3dpi is sufficient to enhance repair, we used 
a pharmacological inhibition of CDK4/6, cyclin dependent kinases crucial for G1/S progression, 
but is a different mechanism than SMC3/HDAC8 mediated cell cycle delay. We induced gent-
AKI in larval zebrafish and treated with Abemaciclib, a known G1/S cell cycle inhibitor, and 
observed the survival rate 271. A cohort of wildtype fish were treated with Abemaciclib or UPHD25 
for positive and vehicle for negative control. Fish treated with Abemaciclib showed a significant 
increase in survival over the DMSO control (Figure 27C). These results suggest that slowing the 
cell cycle during AKI events will promote functional repair. It is possible that hdac8-/-enhance 
survival by using Smc3aAc as a mechanism to slow down cell cycle and drive cellular self-repair, 
before cellular division at 4dpi, whereas wildtypes commence division during injury without this 
cell cycle delay. 
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Figure 27 hdac8 loss of function results in higher SMC3Ac 
 (A)Western blot comparing WT and hdac8-/-. Cytoplasmic and nuclear fractions were ran to identify Smc3a cellular 
localization. Green represents Smc3a. Red represents Smc3aAc. Yellow represents colocalization of both proteins at 
130kDa. (B) Quantification of the WB. 3 biological replicates were conducted. Student’s t-test was used. *p<0.05. 
(C) Survival curves of larvae treated with 8M Abemaciclib, 4M UPHD25, or vehicle (0.5%DMSO). Log-rank 
(Mantel-Cox) test was used compare survival to the control (white). 2 biological replicates were conducted.*p<0.05, 
**p<0.01. 
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4.2.5 hdac8 loss of function reduces RTEC injury 
We have demonstrated loss of hdac8 increases survival after gent-AKI, which is associated 
with a pronounced cell cycle delay. However, the question remained of how the cell cycle delay is 
protecting against injury. Two potential hypotheses were: 1. Absence of HDAC8 function prevents 
damage from occurring; 2. Absence of HDAC8 function enhances repair more efficiently. To test 
these hypotheses, we collected PT cells of injured larvae from early to late (1-4dpi) phases of 
injury to establish the baseline and the progression of injury. To collect pure PT cells, we crossed 
hdac8-/- and WTs to Tg(gtshb:gfp), a PT reporter and used FACS isolation of GFP+ PT RTECs 272. 
500 GFP+ PT cells were sorted from a pool of 60 larvae per condition. Using cDNA synthesized 
from the sorted cells, we quantified kim-1 transcript levels, a marker of RTEC injury. In WT UN, 
kim-1expression was set at baseline during 1-4dpi. WT AKI showed 15-fold increase in expression 
at 1dpi and continues to decrease to 2-fold ( A). hdac8-/-UN had a low baseline kim-1 expression 
(Figure 28A). hdac8-/-AKI also had a low, baseline kim-1 expression comparable to hdac8-/- UN 
(Figure 28B). In comparing WT AKI and hdac8-/-AKI, we found that WT AKI had higher kim-1 
expression than hdac8-/- AKI from1-3dpi (Figure 28B). At 4dpi, WT AKI and hdac8-/-AKI showed 
no difference (Figure 28B).  
The time-course of kim-1 expression suggested that loss of hdac8 is protective against 
injury. However, kim-1 is a downstream marker of RTEC injury. Prior to kim-1 transcription, many 
upstream damage and repair programs are activated. Upon the initial injury, cellular damage 
releases ROS, resulting in DNA breaks 273 274. This DNA damage recruits and activates ATM and 
ATR to the site of damage then increases Chk expression. CHK1 then phosphorylates STAT3 and 
activates the transcription of kim-1 275 (Figure 28C). We hypothesized the cell cycle delay 
mechanism alters more upstream mechanisms, leading to the resolution of damage of RTECs. 
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Therefore, we analyzed the expression of upstream damage response, chk1 or chek1, the zebrafish 
homolog. The expression of chek1 RNA-seq data showed that hdac8-/- had a 40x lower expression 
of chek1 transcripts (Figure 28D), explaining lower expression of kim-1. Results suggest that 
hdac8-/- are not completely protected from injury but may have more efficient repair mechanism 
that resolves injury thereby preventing progression to a worsened outcome.  
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Figure 28 hdac8 loss of function results in reduced kim-1 expression 
 (A) RT-PCR of kim-1 transcripts from PT cells collected from 1dpi (4dpi) to 4dpi (7dpf). Left panel represents WT 
UN (black dots) and AKI (white dots). Right panel represents hdac8-/-UN (black dots) and AKI (white dots).  (B) 
RT-PCR of kim-1 transcripts from PT cells collected from 1dpi (4dpi) to 4dpi (7dpf). Comparison of WT AKI and 
hdac8-/- AKI.  of White dots represent WT AKI. Black dots represent hdac8-/-AKI (C) Proposed pathway of kim-1 
expression by Ajay et al. 275. ROS results in DNA damage and recruits yH2AX. It then triggers a cascade of DDR, 
starting with ATR activation, CHEK1 expression, phosphorylation of STAT3, and ultimately transcriptional 
activation of Kim-1. (D) RNA-seq quantification of chek1 from WT AKI and hdac8-/-AKI. Reads are quantified in 
transcripts per million (TPM).  
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4.2.6 hdac8 loss of function epithelial polarity and reactivation  
To further understand the extent of damage acquired in hdac8-/- fish, we looked at another 
marker of injury, Na+K+ATPase. Na+K+ATPase is an electrogenic transmembrane ATPase, 
expressed in basolateral membrane in steady state PT cells 276. However, upon injury, the epithelial 
polarization is one of the first markers to be disrupted, driving RTECs to lose basolateral 
Na+K+ATPase expression 276 72. Injured RTECs undergo EMT process as repairing cells lose 
epithelial polarity, gain mesenchymal phenotype, dedifferentiate, proliferate, then re-establish 
epithelial polarity 72 20 98. We assessed RTEC epithelial polarity via immunostaining with 
Na+/K+ATPase to assess polarity. We looked at 2 and 3dpi, in uninjured and injured WT and 
hdac8-/- to assess the changes in polarization over time. A semi-qualitative analysis was used score 
RTEC polarization in one of three states: Polarization (intact basolateral expression), partial 
polarization (maintains basal polarization but no distinct lateral expression), or mispolarization 
(complete loss of polarity) (Figure 29A-E). Results showed that at 2dpi 100% WT UN show 
normal basolateral polarity while 100% WT AKI fish show severe loss of polarization of 
Na+/K+ATPase (Figure 29A,B). 100% hdac8-/- UN also showed normal basolateral polarity 
(Figure 29C). Interestingly hdac8-/- AKI showed varying degree of RTEC polarization, with 40% 
of analyzed tubules showing intact polarization (Figure 29D) while 50% showed partial 
polarization (Figure 29E) and 10% mispolarization (Figure 29C-F). By 3dpi, hdac8-/-AKI showed 
ameliorated RTEC health, as there was an increase in intact polarity at 60% and lower percentage 
of partial (30%) and mispolarized (10%) tubules (Figure 29F). Conversely, WT AKI continued to 
display a high percentage of mispolarized tubules at 80% and slight recovery of polarized tubules 
(20%) (Figure 29F). Results suggest hdac8-/- may lead to more efficient EMT and redifferentiation 
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to regain the polarized epithelial phenotype whereas WT further remain in mesenchymal state 
resulting in deterioration of cellular health. 
We then quantified Pax2a, a developmental renal specification gene, which becomes 
reactivated during injury and contributes to new proliferating cells 158 60 98. Since we observed 
hdac8-/- fish with less kim-1 and better polarization, we hypothesized that Pax2a would be 
enhanced to repair and repopulate the epithelium. Using immunofluorescence, we quantified 
Pax2a counts at 3dpi, a known time point that has shown an increase in Pax2a in WT AKI as 
outlined in the previous chapter (Figure 10). Results showed that injury increased Pax2a 
expression in both WT and hdac8-/- (Figure 29G). hdac8-/-AKI shows a significantly higher Pax2a 
than WT AKI (Figure 29G,H). Overall, results suggest that hdac8-/-still accumulates injury, as 
indicated by a change in Na+K+ATPase polarity. However, mutants are protected from further 
progression of injury, as indicated by the lower expression of chek1 and kim-1. Moreover, there is 
higher expression of epithelial genes and lower expression of mesenchymal genes in the mutants, 
suggesting hdac8 loss of function results in more efficient EMT and repolarization of RTECs. The 
injury is reversed more efficiently in the mutants, as seen in the increase expression of Pax2a in 
the mutant RTECs.  
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Figure 29 hdac8 loss of function enhances Na+K+ATPase polarity and Pax2a expression 
(A-F) Immunofluorescence staining of Na+K+ATPase to quantify polarization of RTECs. PT of WT UN 3dpi, WT 
AKI 3dpi, hdac8-/-UN 3dpi, hdac8-/-AKI 3dpi are captured. Na+K+ATPase (red and grey) marks polarization state, 
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GFP (green) marks PT. PT are outlined in white. Scale bar= 20m. (F) Semi-qualitative quantification of 
Na+K+ATPase. Each tubule is scored from 1 of 3 categories: Polarization (black), Partial Polarization (grey), and 
Mispolarization (white). Polarization state was quantified for 2dpi and 3dpi fish. (G)Immunofluorescence staining of 
Pax2a (magenta) RTECs. PT of WT UN 2dpi, WT AKI 2dpi, hdac8-/- UN 2dpi, hdac8-/-AKI 2dpi are captured. Pax2a 
(magenta), GFP marks PT (green), and DAPI marks nuclei (grey). PT are outlined in white. Pax2a are marked with 
white arrows Scale bar= 20m.(H) Quantification of Pax2a+ RTECs. One-way ANOVA was used for statistical 
analysis. Tukey’s multiple comparison test was used for post-hoc. Data pooled from 3 biological replicates are shown 
expressed as mean+/-SEM. *p<0.05. 
4.2.7 hdac8 loss of function results in enhanced DNA damage response and lower apoptosis 
We have shown that AKI in hdac8-/- larvae result in RTEC mispolarization but not a 
concomitant increase in kim-1 expression (Figure 28, Figure 29). This may be due to repair of 
damage upstream to kim-1 while the cell cycle is arrested. Others have also demonstrated that the 
cell cycle delay can be a beneficial repair mechanism since it can allow enough time for resolution 
of genotoxic stress via various DDR mechanisms before mitosis 277 278 279 280. Without proper DDR, 
mitosis causes genome instability, resulting in necrosis and apoptosis 280 278. To test if hdac8-/- 
mutants showed enhanced upstream DNA repair process, I used immunofluorescence assay to 
quantify phospho-gamma H2AX (p-H2A.X), the earliest indicator of DDR 281 277 279. Results show 
that WT UN and hdac8-/- UN both have low expression of p-H2A.X + RTECs (Figure 30A,B). 
However, in AKI setting, hdac8-/- have higher p-H2A.X expression than WT AKI, suggesting 
more damage is being recognized by the DDR complexes. Upon DNA damage, cells undergo 
complex fate determination leading to DNA repair and cell cycle recovery, or apoptosis 78.  
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Figure 30 hdac8 loss of function results in enhanced DNA damage response 
 (A) Immunofluorescence of p-H2A.X to quantify DNA damaged RTECs. PT of WT AKI 2dpi, WT AKI 2dpi, 
hdac8-/- AKI 2dpi, hdac8-/- AKI 2dpi are captured. p-H2A.X (red) marks DNA damaged cells, GFP (green) marks 
PT, DAPI (grey) marks nuclei. PT are outlined in white. Scale bar= 20m. (B)Quantification of p-H2A.X cells in 
PT. One-way ANOVA was used for statistical analysis. Tukey’s multiple comparison test was used for post-hoc. 
Results represented as Mean +/- SEM. *p<0.05  
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To test if hdac8-/- increase in p-H2A.X are fated to be repaired or undergo apoptosis, we 
utilized terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) to quantify 
apoptotic RTECs. Results showed that WT UN and hdac8-/- UN both had a low expression of 
TUNEL+ RTECs (Figure 31A,B). However, in AKI setting, WT AKI and hdac8-/- AKI had 
increased apoptosis compared to WT UN and hdac8-/- UN, respectively (Figure 31A,B). WT AKI 
showed a significantly higher expression of TUNEL+ RTECs than in hdac8-/-AKI (Figure 31A,B). 
Overall, these results suggest that hdac8-/-show increased DDR while preventing RTEC apoptosis. 
The early DDR mechanism may protect the downstream kim-1 expression and prevent further 
damage. 
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Figure 31 hdac8 loss of function results in lower apoptosis 
(A) Immunofluorescence of TUNEL to quantify apoptotic RTECs. PT of WT UN 2dpi, WT AKI 2dpi, hdac8-/-UN 
2dpi, hdac8-/-AKI 2dpi are captured. TUNEL (red) marks apoptotic cells, GFP (green) marks PT, DAPI (grey) 
marks nuclei. PT are outlined in white. Scale bar= 20m. (B) Quantification of TUNEL+ cells in PT. One-way 
ANOVA was used for statistical analysis. Tukey’s multiple comparison test was used for post-hoc. Results 
represented as Mean +/- SEM. *p<0.05 
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4.2.8 RNA-seq shows EMT and cell cycle delay in hdac8 loss of function mutants 
We performed bulk RNA-sequencing with 3dpi fish to identify pathways that activate prior 
to and responsible for the subsequent cell cycle recovery at 4dpi. We crossed hdac8-/- mutants and 
WTs to Tg(gtshb:gfp), and sorted as explained previously 272. Four conditions and two biological 
replicates were collected and sequenced: WT UN, WT AKI, hdac8-/- UN, hdac8-/- AKI (Figure 
32A). In order to validate the RNA-seq data, we compared transcripts of kim-1 and p21, two genes 
previously quantified by RT-PCR (Figure 32B,C). kim-1 was lower and p21 was higher in hdac8-
/- AKI than in WT AKI, both in agreement with the previously reported RT-PCR results (Figure 
26, Figure 28). In addition, we analyzed EMT-related genes, as previous Na+K+ATPase polarity 
data suggested hdac8-/- AKI mutants show enhanced epithelial polarity at 3dpi. Along with 
atp1a1a, the subunits that heterodimerize to form Na+K+ATPase, we also quantified genes that 
have been cited to be involved in EMT transition in RTECs 72 73. Trends suggest WT AKI had 
more mesenchymal gene expression while hdac8-/- AKI had more epithelial gene expression 
(Figure 32D). We then generated a list of genes that were highly upregulated between WT UN and 
WT AKI but downregulated between hdac8-/-UN and hdac8-/-AKI (Figure 32E). The list of genes 
were processed through g:Profiler to acquire a list of enriched pathways, specific to the zebrafish 
genome 282. At 3dpi, hdac8-/- showed lower expression of genes related to innate immune system 
recruitment, sister chromatid cohesion, mitotic spindle checkpoint (Figure 32F). Results suggested 
that genes specifically downregulated in hdac8-/- AKI are genes associated with cell divisions and 
sister chromatid cohesion, which further validates our hypothesis that cell division is halted via 
downregulating SMC3a (Figure 27). Moreover, the results also present candidate mechanisms to 
study in the future in context of HDAC8 and the innate immune system. Results show hdac8-/-AKI 
show lower immune system response, which parallels with our previous finding that PTBA lowers 
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macrophage recruitment, as well as a reduction of the M1 inflammatory macrophages 158(Figure 
18, Figure 20). Taken together, the RNA-seq results not only further validate the previously 
explored results but also allows us to further investigate potential genes and pathways of interest 
in the future.  
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Figure 32 RNA-seq reveals hdac8 loss of function mitigates EMT, immune response, and cell cycle delay. 
(A) Experimental schematic of RNA-sequencing. Tg(gtshb:gfp), PT specific reporter line, was crossed to both WT 
and hdac8-/-. WT UN, WT AKI, hdac8-/-UN, and hdac8-/-AKI were used for RNA-seq. 60 fish per group were 
pooled and dissociated. 500 GFP+ PT cells were isolated using FACS. SMARTSeq HT was used to generate cDNA 
and Nextera-XT was used for library generation. Illumina was used for paired-end 2x75bp to generate 20-30M reads 
per sample. Experiment was done in 2 biological replicates and all samples were sequenced on the same day to 
reduce batch effects. (B-C) Transcripts per million of kim-1 (B) and p21a (C) from RNA-seq data. WT AKI (white) 
and hdac8-/-AKI (black) were quantified .(D)Heatmap of mesenchymal and epithelial genes from the RNA-sea data. 
Each column represents a biological replicate. (E) Heat map of genes upregulated in WT AKI and selection of genes 
with opposite response in hdac8-/- AKI. Differential expression analyses of  WT and hdac8-/- were carried out 
independently then qualitatively identified based on the opposite expression pattern. In WT and hdac8-/- 
comparisons, genes represented were filtered to meet the criteria of FDR p<= 0.05. Each column represents one 
biological replicate (F) List of enriched pathways with the list of genes generated (E) using g:Profiler. Selected 
pathways of interest, immune system, sister chromatid cohesion, mitotic checkpoint, are selected (red).  
4.3 Methods 
4.3.1 Zebrafish husbandry 
Zebrafish husbandry was performed as in Chapter 2  
4.3.2 Gentamicin microinjection 
Gentamicin microinjection was performed as in Chapter 2  
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4.3.3 Survival assays 
After gentamicin injections at 3dpf, each larva was placed in a well of a 48-well plate. The 
larvae were incubated in E3 medium with 50g/ml penicillin/streptomycin. A cohort of 20-30 
larvae were observed for death every day up to 7dpi.  
4.3.4 Compound treatment 
Compound treatment was performed as stated in Chapter 2 
4.3.5 CETSA 
4.3.5.1 CETSA intact cells 
HEK293T cells were transfected with plasmids of specific HDACs containing an N-
terminus Halo tag. Cells were gently washed with TBS three times. 2.5ml of CETSA buffer 
(TBS+Halt protease inhibitor cocktail), (Thermo Fisher Scientific, Cat No.: 78430) was added to 
the plate and gently pipetted up and down to remove the intact cells. The cell suspension was then 
and pipetted into 5ml tube. 620ml of cell suspension was transferred to a 1.5ml centrifuge tube 
and treated with compound to a final concentration of 10M. The same volume of DMSO was 
added to separate aliquot for the negative control. Cells were incubated at 37°C for 1hr. Then, 
45ml of cell suspension and compound were aliquoted into 12 PCR tubes. Each individual sample 
was heated to a single temperature on a gradient ranging from 37-70 in 4°C increments for 5mins, 
followed by 1min at 4°C before cooling on ice. The samples were flash frozen in liquid nitrogen 
followed by thawing at room temperature three times. 
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4.3.5.2 CETSA cell lysates 
HEK293T cells were transfected with plasmids of specific HDACs containing an N-
terminus Halo tag. Cells were gently washed with TBS three times. 2.5ml of CETSA Lysis buffer 
(TBS+ Halt protease inhibitor cocktail, 0.80% NP-40), (Thermo Fisher Scientific) was used to 
scrape cells off the plate. Cell lysis was incubated on ice for 30mins followed by sonication for 
30secs at 10% intensity for 0.5secs pulsing. Cell lysates were then spun for 10mins at 4°C at high 
speed to pellet insoluble components. Supernatant was removed and aliquoted into 620l in1.5ml 
centrifuge tubes and treated with compound to a final concentration of 10M.The same volume of 
DMSO was added to separate aliquot for the negative control. Lysates were incubated at 37°C for 
1hr. Then, 45l of lysates and compound were aliquoted into 12 PCR tubes. Each individual 
sample was heated to a single temperature on a gradient ranging from 37-70 in 4°C increments for 
5mins, followed by 1min at 4°C before cooling on ice 
4.3.5.3 Isothermal dose response curve 
Cell lysates or intact cells were prepared as in the CETSA assays above. 45l samples were 
aliquoted into 12 PCR tubes and treated with 1:1 dilution series of compound with 10M as the 
highest concentration.  Samples were incubated at 37°C for 1hr followed by incubation at 45°C 
for intact cells and 52°C for cell lysates for 5mins followed by cooling at 4°C for 1min before 
cooling on ice.  
4.3.5.4 CETSA/ITDR Western blot 
The samples were the run on a Sorval RC-6 centrifuge with a microplate rotor for 30mins 
at 4000xG. 25ml of supernatant was removed mixed with 5ml 5x loading buffer (bromophenol 
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blue (0.25%) DTT (dithiothreitol; 0.5M)glycerol (50%) SDS (sodium dodecyl sulfate;10%) Tris-
Cl (0.25M, pH 6.8). The samples were heated at 95°C for 5mins followed by 1min at 4°C. Samples 
were spun on a small tabletop centrifuge for 3secs. 25l of the samples were separated on a 10% 
SDS-acrylamide gel, and transferred to a 0.45m MilliporeSigma™ Immobilon™-FL PVDF 
Transfer Membranes (Thermo Fisher Scientific, Cat No.: IPVH00010) and probed with 1:1000 
dilution of mouse anti-HaloTag antibody (Promega, Cat No.: G9211). Infrared dye-conjugated 
secondary antibodies (Li-COR) were used according to the manufacturer's specifications. 
Antibody staining intensity was quantified using an Odyssey CLX system. The percent soluble 
protein was normalized to 37°C for all samples and was fit to the Boltzmann constant sigmoidal 
curve using GraphPad Prism (GraphPad Software, La Jolla California, v7) 
4.3.6 Fin clip and genotyping 
Adult fish were placed in tricaine until gill movement slows and becomes erratic. The 1/3 
of the caudal fin was cut with a clean scalpel and placed in PCR tube. To PCR tube containing fin, 
50l DNA lysis buffer (10mM Tris pH8.4/ 50mM KCl/ 1.5mM MgCl2/ 0.3% Tween-20/ 0.3% 
NP-40) was added to each fin clip. The wells were incubated for 20mins at 94ºC and cooled to 
55ºC. Using the repeat pipette, 5l 10mg/ml proteinase K was added per tube and incubated for 
1hr at 55ºC followed by 94ºC for 20 min. 
To genotype hdac8sa14948, a custom Taqman SNP genotyping assay was designed at the site 
of SNP (Thermo Fisher Scientific; Cat No.: 4332077, Assay No: AN7DPND). Reaction was mixed 
using 2.5l of 2x TaqMan Genotyping Master Mix (Thermo Fisher Scientific, Cat No.: 4371355), 
0.25l 20x Taqman SNP genotyping assay, 1.75l H2O, and 1l of DNA. The assay was ran in a 
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384-well plate and the Genotyping Assay function was used in QuantStudio 12K Flex Real-Time 
PCR system (Thermo Fisher Scientific, Cat No.: 4471090). 
4.3.7 Histological analysis 
Samples were stained as Chapter 2. Antibodies used are provided Table 1. 
4.3.8 EdU incubation 
Fish were treated with 500M EdU (diluted in 1%DMSO and E3) for 24hrs capture cells 
undergoing cell cycling for 24hrs prior to collection. Sections were fixed and sectioned as 
described in Chapter 2. Protocol was slightly adjusted from Click-iT Plus EdU Cell Proliferation 
Kit for Imaging, Alexa Fluor 647 (Thermo Fisher Scientific, Cat No.: C10640). Cryosectioned 
samples are washed using PBS 3 times. Freshly made 1x buffer additive was made for each assay 
by diluting 10x buffer additive with water. For each slide, 130L of the reaction cocktail was made 
(111.8L 1x Click-IT buffer, 5.2L CuSO4, 0.321L Alexa fluor 647 azide, and 13L 1x buffer 
additive). Slides were incubated for 1hr at room temperature. Slides were then washed using PBS 
3 times.  
4.3.9 TUNEL assay 
Cell death was detected using In Situ Cell Death Detection Kit and the provided protocol 
was adapted for zebrafish tissue (Millipore Sigma, Cat No.: 11684795910). Sections were fixed 
and sectioned as described in Chapter 2. Slides were washed with PBS 3 times. Permeabilize 
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sections with sodium citrate buffer (10mM sodium citrate, 0.05% Tween-20, pH 6.0) for 10mins 
at 95C and cool for 1min. Remove 100uL Labelling solution for negative control. For positive 
control, incubate slides with 30U/ml DNase for 10mins at RT prior to Enzyme and Labelling 
solution mixture incubation. Add Enzyme solution to 450L Labelling solution. Mix via pipetting 
and keep on ice.  Incubate slides with Enzyme and Labelling solution mixture at 37C for 1hr. 
Wash with PBS 3 times. Stain nuclei with DAPI as described in Chapter 2.  
4.3.10 Na+K+ATPase staining and embedding 
4.3.10.1 Fixation and staining 
10-15 fish at 5-7dpf were fixed using 1ml Dent’s (80% MeOH, 20% DMSO) for 4hrs at 
RT. They were rehydrated using MeOH/ PBT (PBS with 0.5% Tween20) series from 75%, 50%, 
25% MeOH, each wash for 20mins. Fish were washed with PBT for 20 mins, careful not to expose 
them in air. Fish were incubated in blocking solution (PBS with 1% DMSO, 0.5% Tween20, 10% 
normal goat serum) for 3hrs at 4 °C on a nutator. Fish were incubated with mouse anti- 
Na+/K+ATPase antibody at 1:25 (Developmental Studies Hybridoma Bank, a6F) with incubation 
solution (PBS, 1% DMSO, 0.5% Tween20, 2% Normal goat serum) overnight at 4°C on a nutator. 
Samples were washed with incubation solution for 30 mins, three times. Fish were incubated with 
secondary antibody (Goat anti-mouse Alexa fluor 594, Abcam, ab150116) at 1:500 using 
incubation solution (fixation and embedding will give off autofluorescence at FITC channel). 
Samples were washed with PBT for 30 mins, three times.  
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4.3.10.2 Embedding  
Stained tissues were dehydrated using EtOH/PBT series from 50%, 75%, 100% EtOH. JB-
4 embedding solutions were prepared (Polysciences, 00226-1): Solution1 Infiltration solution: 
25mL of solution A and 0.25g of plasticized benzoyl peroxide; Solution2 Embedding plastic: 35µL 
of solution B per 1mL of Infiltration solution. Fish were incubated with the pre-made infiltration 
solution for 30min at room temperature. Infiltration can be stored in 4C for up to 1 month. 
Molding was labeled and filled with 2ml prepared embedding plastic. Working in small volumes 
(5-10mL) will reduce the exothermic reaction of the catalyst and will slow down the 
polymerization process and allow longer time to embed samples. 5-10 samples were mounted per 
mold. EBH-2 Block Holders (Polysciences, 15899) were used as a chuck for samples. For proper 
polymerization, the mounted samples were stored in a vacuum overnight at room temperature.  
4.3.10.3 Sectioning 
The mounted and polymerized samples were sectioned at 4M transversally using a 
Shandon Finesse microtome (Thermo Fisher Scientific). Sections containing pronephros were 
collected on glass slides over DI water. Slides containing sections were incubated on 45C slide 
warmer and stored until completely dry. Sections were cover slipped and imaged using confocal 
microscopy as described in Chapter2. 
4.3.11 Zebrafish larvae homogenization 
The protocol was adapted from Bresciani et al 283. Dissociation mix was using 460μl 0.25% 
trypsin-EDTA + 40μl Collagenase 100 mg/ml. DMEM-10% FBS was prepared. They were made 
from fresh aliquots each time. The solutions were pre-heated at 30C. The rest of the protocol was 
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carried out at room temperature with as little delay as possible to maintain cell survival. 30 
zebrafish larvae of age 4-7dpf were anesthetized using tricaine and washed with PBS and replaced 
with 500l pre-heated dissociation mix. Fish were mechanically dissociated via harsh pipetting 
using P1000. Samples were pipetted swiftly 100 times, for about 5mins. To stop dissociation, 
800l DMEM-10% FBS was added. The sample was mixed and centrifuged 5mins at 800g at room 
temperature. The supernatant was discarded. The pellet was resuspended with 1ml of PBS and 
centrifuged at 800g at room temperature. The samples were then resuspended in 1ml of DMEM-
10% FBS. Cells were passed through 40m filter in order to reduce debris and cell aggregates. 
Depending on downstream application, such as fluorescence activated cell sort, resuspend the cells 
in 500l of 1X propidium iodide (PI, in 1X PBS) to stain for live and dead cells (Abcam, 
ab139418). 
4.3.12 Fluorescence Activated Cell Sort 
Live, single cell suspension of PT reporter zebrafish line, Tg(gtshb:gfp), was used to isolate 
GFP+ PT RTECs 272. For each experimental group, 60 zebrafish larvae were pooled and 
homogenized using the previously mentioned protocol 283, in 500l 1X PI. To differentiate auto-
fluorescent cells during gating, age-matched, wildtype embryos were prepared along with 
experimental samples. Samples of nonfluorescent embryos were used to set sorting gates. Cells 
were sorted at the Rangos Flow Cytometry Core (Pittsburgh, PA) using LSR II Flow Cytometer 
(BD Biosciences). Gating varies from samples and instruments. Briefly, single cell suspension was 
gated using SSC-A and FSC-A to isolate cells from debris. Then, FSC-W and FSC-H were used 
to gate and isolate single cells. FSC-A and PE-Texas Red-A was used to isolate live single cells 
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(PI-) from dead cells (PI+). FIT-C channel was used to isolate GFP+, only gating those that do not 
overlap with wildtype GFP- control, at 103 fluorescence unit. For each experimental group, total 
of 500 cells were collected into 96-well plate filled with Smart-Seq HT sorting buffer for 
downstream protocols 
4.3.13 RT-PCR 
Zebrafish larvae at 1-4 dpi (4-7dpf) were homogenized and sorted as stated above. For each 
timepoint, four conditions were collected: WT UN, WT AKI, hdac8-/- UN, hdac8-/- AKI. Due to 
the low GFP+ PT cell count, a low-sample cDNA generation kit was used to directly amplify 
cDNA from sorted cells. 500 isolated GFP+ PT cells were collected in Smart-Seq HT kit sorting 
buffer in 96-well plate (Takara Bio USA, 634455). Per Smart-Seq HT kit manual, the one-step 
first-strand cDNA synthesis and quantification was performed carried out at the Health Sciences 
Sequencing Core at Children’s Hospital of Pittsburgh (Pittsburgh, PA). cDNA was quantified 
using Qubit. The generated cDNA for all samples were diluted to a working stock of 1ng/l. The 
primers were diluted to working stock of 10M. SYBR Green RT-PCR was performed out in a 
10l reaction (3.6l SYBR Green PowerUp 2X, 3.6l RNase-free H2O, 0.8l 1:5 cDNA, 4.4l 
1:10 reverse and forward primers) (Thermo Fisher Scientific, A25742). Each reaction was run in 
triplicates. Primer sequences are provided in Table 2. 
4.3.14 cDNA library preparation and RNA-sequencing 
Zebrafish larvae at 3dpi (6dpf) were homogenized and sorted as stated above. For each 
timepoint, four conditions were collected: WT UN, WT AKI, hdac8-/- UN, hdac8-/- AKI. cDNA 
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synthesis, quantification, library preparation, and sequencing were performed as stated above and 
carried out at the Health Sciences Sequencing Core at Children’s Hospital of Pittsburgh 
(Pittsburgh, PA). Nextera XT kit was used to generate unstranded, mRNA-specific enriched library 
according to the manufacturer’s protocol (Illumina, FC-131-1096). Final libraries were normalized 
to 10nM, pooled and diluted. NextSeq 500 (Illumina) was seeded with 1.8pM denatured library 
for automated cluster formation for approximately 30- to 40- million reads per sample. 
4.3.15 RNA-seq analysis 
Hisat2 (v2.1.0) 284 was used to align paired-end RNA-seq reads to the zebrafish reference 
genome (UCSC danRer11) and gene-level counts per million (CPM) were calculated using 
featureCounts 225 and edgeR 226. Pathway analysis was performed by inputting list of differentially 
expressed genes from the said analysis. g:Profiler was used for pathway enrichment, selecting 
Danio rerio as the host organism (Elixer, Estonia). 
4.3.16 Statistical analysis 
Data were analyzed using Student’s t-test, one-way ANOVA, two-way ANOVA, and Log-
rank (Mantel-Cox) as indicated, and data are reported as mean±SEM. P-values were considered 
significant when <0.05. For immunofluorescence studies in zebrafish larvae, Each dot on 
graphs reflects the number of pronephros included in the analysis per group. When visible, both 
nephrons per fish were included.  
  120 
4.4 Discussion 
We have identified HDAC8 as the target of PTBA and elucidated the role HDAC8 plays 
in progression of AKI. Various HDIs have been used to enhance regenerative capacity of the 
kidney in the past. However, the non-selective nature of various pan-HDIs has confounded the 
underlying reparative mechanisms conferred by these drugs. Here, we were able to use CETSA to 
show the selective binding of PTBA to an HDAC class I member, HDAC8. We also demonstrated 
in vivo selectivity by treating WT and hdac8-/-gent-AKI zebrafish larvae with PTBA analog, 
UPHD25 and showing hdac8-/- mutants results in no compound efficacy. We demonstrated that 
PTBA’s efficacy depends on the presence of HDAC8. 
Since PTBA was validated as a selective HDAC8 inhibitor, the next step was to assess the 
effect of genetic deletion of HDAC8 in AKI. While homozygous mutants were viable until 
adulthood, 1% developed craniofacial deformities. HDAC8 is one of the mutations identified in 
CdLS patients, but does not result in embryonic lethality unlike other class I HDAC knockouts. In 
mice, HDAC8 loss of function results in embryonic viability, but shorter lifespan, due to 
craniofacial and brain deformities. A more in-depth developmental and cognitive characterization 
through embryonic to adult stages may be an interesting question to those interested in the role 
HDAC8 plays in CdLS. For our purpose, however, we focused our attention on AKI progression. 
In hdac8-/- there was a significant increase in survival compared to WT, which phenocopies 
PTBA’s efficacy in increasing survival rate of zebrafish after AKI. 
During AKI, more cells undergo cycling to eventually repopulate lost RTECs. In WT 
zebrafish, RTEC proliferation occurs at 3dpi, as seen by an increase EdU/pH3 staining. However, 
in hdac8-/- the RTEC completion of the proliferation response does not occur at 3dpi, but rather 
delayed at 4dpi. At this later timepoint, both EdU and pH3 both are significantly higher than WT 
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AKI. This delay in cycling was further supported by the p21a qPCR quantification. As EdU and 
pH3 expression go up, p21 expression is lowered. This is concomitant to cell cycle recovery, with 
lowering of checkpoint inhibitor and progression from G1/S to G2/M 78. This cell cycle delay can 
possibly be explained by HDAC8 association with SMC3a, a member of the cohesin ring. Without 
HDAC8, SMC3a cannot be recycled into the next cell cycle, therefore cycling cells progress more 
slowly 186,202. Because there is a freshly translated SMC3a, cell cycle continues to occur but it is 
theorized to be achieved at a slower rate 186,190. This hypothesis that slower cell cycling may be 
beneficial for damaged cells undergoing repair was supported when we treated fish with 
Abemaciclib, a CDK4/6 inhibitor 271. Inhibition of cell cycle increased survival of larval zebrafish 
with gent-AKI. This is hypothesized to be due to prolonged DDR response prior to S and G2/M 
phase, which is more error-prone and therefore likely to lead to genomic instability. This is in line 
with past AKI studies that have shown that careful modulation of cell cycling, for example with 
other pharmacological inhibitors of CDK4/6, will lead to enhanced AKI recovery 81-83. 
We looked at DDR response and apoptosis, to see if HDAC8 and its delay in cell cycle is 
leading to more efficient and enhanced repair response. In hdac8-/-, RTECs showed higher pH2ax 
expression of at 2dpi, during the period of delay. The p-H2A.X was also accompanied by lower 
TUNEL+ staining. Increased pH2ax expression in hdac8-/- suggests that mutants are indeed injured 
by gent-AKI as p-H2A.X levels indicate first signs of DDR. Lower cell death, however, suggests 
that the damage is repairing and preventing downstream apoptotic response. There are multiple 
pathways that can be activated downstream of p-H2A.X. For example, DDR proteins 
(MRE1/NBS1/RAD50, MDC1, 53BP1, BRCA1) can colocalize with p-H2A.X and activate ATM 
281. P-H2A.X also associate with checkpoint phosphorylation, chromatin remodeling, cohesin 
recruitment, which all result in further cell repair mechanisms 281.  
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Further analysis of the hdac8-/- mutants revealed that EMT-related genes were differentially 
expressed between WT and hdac8-/-. A very recent study is in concurrence with our findings, also 
citing HDAC8 inhibition results in less EMT and less cell cycle arrest 195. During injury, damaged 
RTECs undergo EMT and reactivate developmental genes, such as pax2 and sox9, as a mechanism 
to proliferate and repopulate the damaged proximal tubule98. However, prolonged mesenchymal 
state has also been associated with damage and cellular senescence, as those cells increase in pro-
fibrotic factors 67,72,73. Analysis of earlier timepoints at 2 and 3dpi, suggests that hdac8-/- fish 
undergo EMT, but lower than in WT. Even though there is a change in dynamics of EMT, the 
reactivation gene Pax2a is still expressed in the mutants. It would be interesting to test if the 
mesenchymal cells are the source of Pax2a expression in hdac8-/- RTECs. As prolonged 
mesenchymal state results in further inflammation and profibrotic response, it would be interesting 
to see if hdac8-/--mediated efficient EMT occurrence results in less fibrosis in a long-term study. 
Mice and human organoids will be both accessible and serve as more translatable models to study 
long term effects of hdac8 deletion. One caveat of the study was the universal deletion of hdac8-/-
. By utilizing a global knock out of hdac8-/-, we still have not teased apart the effect HDAC8 on 
specific tissues and its potential negative effects it may have in other cycling cells. There are other 
known targets of HDAC8, such as ERR, cortactin, and p53. It would be worthwhile to conduct 
proximal tubule specific acetylomics to understand a wide range of targets that exist that may 
contribute to this enhanced repair process.   
Overall, this study not only identified HDAC8 as PTBA target, but more importantly we 
were able to characterize the role of HDAC8 in isolation from other class I HDACs in a zebrafish 
AKI model. We have demonstrated that genetic deletion of hdac8 results in cell cycle delay due 
to hyper-acetylation of Smc3a. This hdac8-/--driven cell cycle delay during injury serves as a 
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beneficial phenomenon. The delay is associated with prevention of irreversible damage: enhancing 
DDR response and preventing kim-1 expression and apoptosis. The extent of damage may be less 
severe in delayed RTECs, allowing EMT and redifferentiation to fully polarized epithelial cells to 
be established. HDAC8, unlike its class I family members, does not impart developmentally lethal 
conditions. HDAC8 may be playing a role as a bimodal regulator to independently regulate two 
pathways: to delay cell cycle as well as reducing EMT. This study demonstrates that HDAC8 is a 
promising candidate for selective pharmacological inhibition, as it may result in an accurate and 
targeted repair response without conferring critical off-target and side effects. This work 
demonstrates a potential target of interest for AKI and a novel mechanism of cell cycle delay to 
achieve enhanced damage response via HDAC8 inhibition.   
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Additional contributors to the chapter 
Amanda Crunk and Christina Crana performed CETSA and Western blots 
Michael McDaniels performed survival assays 
Abha Bais performed RNA-seq analysis 
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5.0 General discussion 
Collectively, our finding furthers PTBA’s mechanism of action as well as identifying a 
novel target and mechanisms involved in the progression of AKI. We’ve determined that PTBA 
enhances RTEC dedifferentiation, reduces cellular injury, and requires intact RA pathway for 
efficacy. We’ve characterized the zebrafish leukocyte activation during AKI and its changes under 
PTBA administration. Lastly, we identified the target of PTBA, HDAC8, using in vivo and in vitro 
methods. Using mutant zebrafish, we validated that genetic ablation of hdac8 results in enhanced 
survival, RTEC cell cycle delay, decreased injury, efficient EMT, and overall better repair than 
WT (Figure 33).  
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Figure 33 HDAC8 inhibition results in enhanced repair 
PTBA selectively binds to HDAC8. HDAC8 is implicated in cell cycle progression via deacetylating SMC3 (green). 
When HDAC8 is inhibited, cell cycle delay and recovery occurs in actively dividing RTECs. This delay and 
subsequent recovery allows longer time for DNA repair prior to cell division, as supported  by increased number of  
H2AX-positive RTECs and enhanced RTEC epithelial polarity. 
 
Perhaps the most exciting finding is the identification and further characterization of 
HDAC8’s role in AKI injury response. We first wanted to validate the claim that PTBA enhances 
repair by inhibiting HDAC8. We’ve identified many reparative phenotypes consistent with hdac8-
/- mutants and PTBA treatment in wildtype fish. hdac8-/- and PTBA treated WT similarly displayed 
enhanced survival, increased cell cycling, enhanced reactivation of Pax2a, and reduced kim-1 
expression, and reduced apoptosis 156. Earlier experiments validated that PTBA enhances 
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proliferating PCNA+ RTEC population. However, PCNA is a wider marker of cell cycle phases 
(S, G2, and M) and therefore cell-cycle specific staining and the use of FACS will further 
characterize the cell cycle dynamics in detail. The newly identified repair mechanisms in hdac8-/- 
are cell cycle delay, increased epithelial polarity, and enhanced p-H2A.X. These are 
characterizations in hdac8-/- fish that should also be repeated for PTBA treated fish. 
There are other phenomena which diverge between PTBA and hdac8-/-. In PTBA treated 
fish, we see enhanced EMT, a phenomenon required for dedifferentiation and proliferation of 
RTECs. In hdac8-/-, the EMT process is less pronounced, with the RNA-seq results showing more 
epithelial genes and protein expression. EMT, however, is a multifaceted physiological that also 
presents problems during maladaptive repair. Maladaptive RTECs, along with mesenchymal 
factors, can co-express pro-inflammatory cytokines and pro-fibrotic factors 194. To parse out 
whether EMT is serving as a regenerative dedifferentiation or injury, the RNA-seq data was 
analyzed for expression of pro-inflammatory and pro-fibrotic factors. Both AKI+UPHD25 
wildtype fish and hdac8-/- AKI fish expressed lower levels of tgfb, tnfa, mmp, col, and ils compared 
to their AKI+DMSO  or WT AKI controls, respectively (data not shown). Results suggest that 
EMT serves a regenerative purpose to drive dedifferentiation, not fibrosis, in our experimental 
models.  
Overall variable results between PTBA and hdac8-/- likely due to the differences in of 
HDAC8 inhibition. PTBA serves as a temporary HDAC8 inhibition, treated after the injury 
response is occurring, and the compound is metabolized and rendered ineffective within 6hr of 
treatment. 176 156. This contrast in HDAC8 inhibition dosage may affect the results and phenotypes 
we observe. A recent study by Wen et al. has shown treatment time and dosage is critical in 
drawing optimal PTBA efficacy 211. This may be due to the time-sensitive nature of other signaling 
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pathways that are activated and crosstalk with PTBA. Previous work in the lab has shown RA 
response occurs in RTECs within the first 7hrs of gent-AKI 157. p21 activity during early phases 
of injury is beneficial, whereas prolonged p21 activity leads to worsened outcome in mouse models 
84,85 273. It would be critical to identify and treat patients at the right window of disease progression. 
It will be important to assess efficacy of inducible, tissue-specific hdac8 knockout model. This 
would enable further delineation of HDAC8 function at different timepoints of injury progression. 
Certain mechanisms explored in the PTBA study are yet to be explored in the hdac8-/- 
model. In our current work and past studies, intact RA signaling pathway is necessary for PTBA 
efficacy as well as conferring regenerative effects in AKI setting 157 166 247 246. We suspect hdac8-
/- mutants will enhance the endogenous RA response in injury setting. Others have shown links 
between HDAC8 and RA signaling pathway. Cotreatment of HDAC8 inhibitor, PCI-34051, and 
exogenous RA treatment showed a positive synergistic effect in differentiating neuroblastoma cells 
285. HDAC8 and RA pathways converge at pCREB (phospho-cAMP-response element-binding 
protein), necessary for cellular proliferation during organ repair setting and kidney 
dedifferentiation 286 287 288 289. RA positively regulates pCREB activation while HDAC8 negatively 
regulates pCREB 285 290. Inhibition of HDAC8, along with endogenous increase of RA activity in 
the kidney, pCREB may become synergistically activated thereby conferring regenerative effect 
in the kidney.  
Another system yet to be explored in the hdac8-/- model is the immune system. Studies 
have shown HDAC8 inhibition shows anti-inflammatory effect as well as modulating 
macrophages transcriptional response to toxins 191,193,291. Overall, HDAC8 inhibition has shown 
decline in inflammatory response in various injury models 191,193. Studies have also shown a direct 
link between HDAC8 and cortactin, a key regulator of actin cytoskeleton responsible for f-actin 
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polymerization 292,293. Cortactin is a known substrate of HDAC8 deacetylase activity and is 
implicated in cellular motility, especially migratory cells such as leukocytes and osteoclasts 294,295 
293. Our current RNA-seq data further validates decrease of innate immune response in hdac8-/- 
model. With the techniques optimized throughout this study, more in-depth studies are now 
accessible. Macrophage infiltration and polarization dynamics can be studied in hdac8-/- fish using 
real time 2-photon confocal imaging and FACS.  
In developing therapeutics, cell type specificity of a candidate drug is important 296. The 
next step in PTBA development is to identify its main cellular target Generation of PT-specific or 
macrophage-specific inducible hdac8 knockout models will delineate the answer. Another method 
will be to analyze the effect of PTBA in an isolated kidney setting, using organoids, in which 
human iPCS is differentiated to tubules, blood vessels, and interstitium 297. Preliminary studies in 
our group have shown organoids can serve as a model for interstitial fibrosis (unpublished). 
Utilizing the human-derived organoids will serve as a partner to our zebrafish model, validating 
the current findings and assessing long-term effects such as interstitial fibrosis 298. The Hukriede 
lab is currently in the process of establishing hdac8 knockout organoids to understand the role of 
HDAC8 in a more translationally relevant setting. 
Overall, this study shines light on the zebrafish, in conjunction with cell-based assays, as 
an enduring model of AKI to continue PTBA characterization. In the past, the Hukriede lab first 
initiated the search to fulfill the lack of AKI therapeutics by using zebrafish embryos to perform 
large phenotypic screening to identify our candidate compound 148. Then, our lab transitioned to 
take advantage of the conserved nature of the zebrafish pronephros and their injury response to 
gent-AKI 155,156. Our current study used these past studies as a stepping-stone to further our 
understanding of PTBA efficacy, biomarker response, as well as target identification, both in vitro 
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and in vivo. In doing so, we have identified HDAC8 as a novel target and its mechanisms 
underlying the enhanced repair response. This work provides an insight on cellular repair 
mechanisms and one more step on finding a cure for acute kidney injury. 
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Appendix A Antibodies used for histology 
Table 1 Antibodies and antigen retrieval protocol for histology 
Primary antibodies 
Antigen Source Cat# 
Host 
species Dilution Tissue 
Antigen 
retrieval 
3G8 DSHB 3G8.2C11 Mouse 1:200 Frozen None 
Pax2a GeneTex 
GTX12812
7 Rabbit 1:200 Frozen Citrate 
GFP Aves Labs GFP-1020 Chicken 1:300 Frozen None/Citrate 
Kim-1 R&D Systems MAB1817 Rat 80µg/ml Frozen None 
Dendra2 Origene TA180094 Mouse 1:200 Frozen None 
TNF⍺ AnaSpec AS-55383 Rabbit 1:100 Frozen Citrate 
Arginase2 Thermo Fisher PA5-27987 Rabbit 1:100 Frozen Citrate 
PCNA Sigma P8825 Mouse 1:3000 Frozen Citrate 
E-Cadherin 
BD 
Biosciences 610182 Mouse 1:200 Frozen Citrate 




2 Rabbit 1:200 Frozen Citrate 
p-Histone H3 Ser Cell Signaling 9701 Rabbit 1:100 Frozen   
Na+K+ATPase DSHB a6F Mouse 1:25 JB4 embedded None 
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Table 1 continued 
 
Secondary antibodies 
Antigen Source Cat# 
Host 
species Dilution Tissue Conjugate 
Goat anti-mouse Abcam ab97035 Goat 1:1000 Frozen Cy3 
Goat- anti-rabbit Thermo Fisher A-11008 Goat 1:1000 Frozen Alexa488 
Goat- anti-mouse Thermo Fisher A-11001 Goat 1:1000 Frozen Alexa488 
Goat anti-rat Thermo Fisher A-11007 Goat 1:1000 Frozen Alexa594 
Donkey anti-rabbit Thermo Fisher A-10042 Donkey 1:1000 Frozen Alexa568 
Goat anti-chicken Thermo Fisher A-11039 Goat 1:1000 Frozen Alexa555 





       
       
Antigen retrieval 
Method Reagents Cat# Protocol 
Trypsin Trypsin from porcine 
pancreas 
Sigma-aldrich,T7168 Dissolve 1 tablet/100mL ddH2O. Incubate 
slides at 37C for 30m 
Sodium citrate buffer Citric acid Sigma-aldrich, 251275 10mM Sodium citrate, 0.05% Tween-20. 
pH=6.0. Incubate slides at 97C for 30m. 
Cool for 30 m at room temperature 
Tween-20 Sigma-aldrich, P1379 
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Appendix B RT-PCR primer sequence 
Table 2 RT-PCR primer sequences 
Gene Forward primer sequence Reverse primer sequence 
hdac8 GCCCACCCTCTTGTGTTTCA CACCTAATATTCTCTCTTGCCGTA 
p21 CCTACGTTCACTCGGTAA CTGTGATGTTGGTCTGTTT 
actb1 CCGTGACATCAAGGATAAGCT TCGTGGATACCGCAAGATTCC 
eef1a1l1 ATCGACCGTCGTTCTGGCAAG AACGGTGTGATTTGAGGGAA 
kim1 CGCTAGAAGTAAGGCAGAA CACTGTTCGTATTCGCTTTC 
bactin CGTGCTGTCTTCCCATCCA TCACCAACGTAGCTGTCTTTCTG 
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